{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:07:27Z","timestamp":1792789647949,"version":"4.5.0"},"reference-count":257,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["NUHSRO\/2023\/039\/RO5+6\/Seed-Mar\/04"],"award-info":[{"award-number":["NUHSRO\/2023\/039\/RO5+6\/Seed-Mar\/04"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02246-4","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:58:01Z","timestamp":1747720681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gene therapy for age-related macular degeneration: a promising frontier in vision preservation"],"prefix":"10.1186","volume":"23","author":[{"given":"Kiavash","family":"Hushmandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiu Yan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Meihua","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wency","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Hashem","family":"Daryabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najma","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Prem","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"10153","key":"2246_CR1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147\u201359.","journal-title":"Lancet"},{"key":"2246_CR2","doi-asserted-by":"crossref","unstructured":"de Jong EK, Geerlings MJ, den Hollander AI. Age-related macular degeneration. Genetics and genomics of eye disease. 2020:155\u2013\u200980.","DOI":"10.1016\/B978-0-12-816222-4.00010-1"},{"issue":"1","key":"2246_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gendis.2021.02.009","volume":"9","author":"Y Deng","year":"2022","unstructured":"Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L. Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis. 2022;9(1):62\u201379. https:\/\/doi.org\/10.1016\/j.gendis.2021.02.009.","journal-title":"Genes Dis"},{"issue":"11","key":"2246_CR4","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","volume":"123","author":"MD Davis","year":"2005","unstructured":"Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, Ferris FL, Bressler SB, Milton RC. Age-Related eye disease study G. The Age-Related eye disease study severity scale for age-related macular degeneration: AREDS report 17. Arch Ophthalmol. 2005;123(11):1484\u201398. https:\/\/doi.org\/10.1001\/archopht.123.11.1484.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"2246_CR5","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","volume":"123","author":"FL Ferris","year":"2005","unstructured":"Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, Milton RC, Bressler SB, Klein R. Age-Related eye disease study research G. A simplified severity scale for age-related macular degeneration: AREDS report 18. Arch Ophthalmol. 2005;123(11):1570\u20134. https:\/\/doi.org\/10.1001\/archopht.123.11.1570.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"2246_CR6","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.ophtha.2016.05.043","volume":"123","author":"G Liew","year":"2016","unstructured":"Liew G, Joachim N, Mitchell P, Burlutsky G, Wang JJ. Validating the AREDS simplified severity scale of Age-Related macular degeneration with 5- and 10-Year incident data in a Population-Based sample. Ophthalmology. 2016;123(9):1874\u20138. https:\/\/doi.org\/10.1016\/j.ophtha.2016.05.043.","journal-title":"Ophthalmology"},{"key":"2246_CR7","doi-asserted-by":"crossref","unstructured":"Ashique S, Kumar S, Hussain A, Farid A, Mishra N, Garg A. Age-associated macular degeneration: epidemiologic features, complications, and potential therapeutic approaches. Targeting angiogenesis, inflammation, and oxidative stress in chronic diseases. Elsevier; 2024. pp. 381\u2013429.","DOI":"10.1016\/B978-0-443-13587-3.00010-2"},{"issue":"1","key":"2246_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ophtha.2007.03.008","volume":"115","author":"TY Wong","year":"2008","unstructured":"Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008;115(1):116\u201326. https:\/\/doi.org\/10.1016\/j.ophtha.2007.03.008.","journal-title":"Ophthalmology"},{"key":"2246_CR9","doi-asserted-by":"publisher","first-page":"8374647","DOI":"10.1155\/2018\/8374647","volume":"2018","author":"LF Hernandez-Zimbron","year":"2018","unstructured":"Hernandez-Zimbron LF, Zamora-Alvarado R, Ochoa-De la Paz L, Velez-Montoya R, Zenteno E, Gulias-Canizo R, Quiroz-Mercado H, Gonzalez-Salinas R. Age-Related macular degeneration: new paradigms for treatment and management of AMD. Oxid Med Cell Longev. 2018;2018:8374647. https:\/\/doi.org\/10.1155\/2018\/8374647.","journal-title":"Oxid Med Cell Longev"},{"key":"2246_CR10","doi-asserted-by":"publisher","first-page":"102322DOI","DOI":"10.1016\/j.arr.2024.102322","volume":"98","author":"P Kumbhar","year":"2024","unstructured":"Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Andreoli Pinto TJ, Paiva-Santos AC, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: breakthroughs and bottlenecks. Ageing Res Rev. 2024;98:102322DOI. https:\/\/doi.org\/10.1016\/j.arr.2024.102322.","journal-title":"Ageing Res Rev"},{"key":"2246_CR11","doi-asserted-by":"crossref","unstructured":"Fairbanks AM, Husain D, editors. Controversies and disparities in the management of Age-Related macular degeneration. Seminars in ophthalmology. Taylor & Francis; 2023.","DOI":"10.1080\/08820538.2022.2152705"},{"issue":"10411","key":"2246_CR12","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Mones J, Singh RP, Ribeiro R, Wykoff CC. Oaks, investigators Ds. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402(10411):1434\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(23)01520-9.","journal-title":"Lancet"},{"issue":"12","key":"2246_CR13","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1097\/MS9.0000000000001466","volume":"85","author":"A Nadeem","year":"2023","unstructured":"Nadeem A, Malik IA, Shariq F, Afridi EK, Taha M, Raufi N, Naveed AK, Iqbal J, Habte A. Advancements in the treatment of geographic atrophy: focus on Pegcetacoplan in age-related macular degeneration. Ann Med Surg (Lond). 2023;85(12):6067\u201377. https:\/\/doi.org\/10.1097\/MS9.0000000000001466.","journal-title":"Ann Med Surg (Lond)"},{"issue":"5","key":"2246_CR14","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1097\/MS9.0000000000002021","volume":"86","author":"L Shakeel","year":"2024","unstructured":"Shakeel L, Khan A, Akilimali A. Izervay (avacincaptad pegol): paving the way for vision preservation in geographic atrophy. Ann Med Surg (Lond). 2024;86(5):2413\u20136. https:\/\/doi.org\/10.1097\/MS9.0000000000002021.","journal-title":"Ann Med Surg (Lond)"},{"issue":"15","key":"2246_CR15","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s40265-023-01948-8","volume":"83","author":"C Kang","year":"2023","unstructured":"Kang C. Avacincaptad Pegol: first approval. Drugs. 2023;83(15):1447\u201353. https:\/\/doi.org\/10.1007\/s40265-023-01948-8.","journal-title":"Drugs"},{"issue":"6","key":"2246_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.ophtha.2011.12.016","volume":"119","author":"MA Singer","year":"2012","unstructured":"Singer MA, Awh CC, Sadda S, Freeman WR, Antoszyk AN, Wong P, Tuomi L. HORIZON: an open-label extension trial of Ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology. 2012;119(6):1175\u201383. https:\/\/doi.org\/10.1016\/j.ophtha.2011.12.016.","journal-title":"Ophthalmology"},{"issue":"8","key":"2246_CR17","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"G Research","year":"2016","unstructured":"Comparison of Age-related Macular Degeneration Treatments Trials, Research G, Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL. Five-Year outcomes with Anti-Vascular endothelial growth factor treatment of neovascular Age-Related macular degeneration: the comparison of Age-Related macular degeneration treatments trials. Ophthalmology. 2016;123(8):1751\u201361. https:\/\/doi.org\/10.1016\/j.ophtha.2016.03.045.","journal-title":"Ophthalmology"},{"issue":"2","key":"2246_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","volume":"99","author":"FG Holz","year":"2015","unstructured":"Holz FG, Tadayoni R, Beatty S, Berger A, Cereda MG, Cortez R, Hoyng CB, Hykin P, Staurenghi G, Heldner S, Bogumil T, Heah T, Sivaprasad S. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol. 2015;99(2):220\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305327.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2246_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajo.2012.06.031","volume":"155","author":"MK Falk","year":"2013","unstructured":"Falk MK, Kemp H, S\u00f8rensen TL. Four-year treatment results of neovascular age-related macular degeneration with Ranibizumab and causes for discontinuation of treatment. Am J Ophthalmol. 2013;155(1):89\u201395. e3.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2246_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/IAE.0000000000000827","volume":"36","author":"JF Arevalo","year":"2016","unstructured":"Arevalo JF, Lasave AF, Wu L, Acon D, Berrocal MH, Diaz-Llopis M, Gallego-Pinazo R, Serrano MA, Alezzandrini AA, Rojas S, Maia M, Lujan S, Pan-American Collaborative Retina Study G. INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION. 5-Year results of the Pan-American collaborative retina study group. Retina. 2016;36(5):859\u201367. https:\/\/doi.org\/10.1097\/IAE.0000000000000827.","journal-title":"Retina"},{"key":"2246_CR21","doi-asserted-by":"crossref","unstructured":"Sengillo JD, Justus S, Tsai YT, Cabral T, Tsang SH, editors. Gene and cell-based therapies for inherited retinal disorders: an update. American journal of medical genetics part C: seminars in medical genetics. Wiley Online Library; 2016.","DOI":"10.1002\/ajmg.c.31534"},{"issue":"10","key":"2246_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1080\/14712598.2017.1356817","volume":"17","author":"NA Moore","year":"2017","unstructured":"Moore NA, Bracha P, Hussain RM, Morral N, Ciulla TA. Gene therapy for age-related macular degeneration. Expert Opin Biol Ther. 2017;17(10):1235\u201344. https:\/\/doi.org\/10.1080\/14712598.2017.1356817.","journal-title":"Expert Opin Biol Ther"},{"key":"2246_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-genom-090413-025610","volume":"15","author":"LG Fritsche","year":"2014","unstructured":"Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet. 2014;15:151\u201371. https:\/\/doi.org\/10.1146\/annurev-genom-090413-025610.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"5720","key":"2246_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"RJ Klein","year":"2005","unstructured":"Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385\u20139. https:\/\/doi.org\/10.1126\/science.1109557.","journal-title":"Science"},{"issue":"5720","key":"2246_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","volume":"308","author":"JL Haines","year":"2005","unstructured":"Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308(5720):419\u201321. https:\/\/doi.org\/10.1126\/science.1110359.","journal-title":"Science"},{"issue":"5720","key":"2246_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308(5720):421\u20134. https:\/\/doi.org\/10.1126\/science.1110189.","journal-title":"Science"},{"issue":"2","key":"2246_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1167\/iovs.05-1143","volume":"47","author":"T Sepp","year":"2006","unstructured":"Sepp T, Khan JC, Thurlby DA, Shahid H, Clayton DG, Moore AT, Bird AC, Yates JR, Group GFiAS. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Investig Ophthalmol Vis Sci. 2006;47(2):536\u201340.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"2246_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.296.3.301","volume":"296","author":"DD Despriet","year":"2006","unstructured":"Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van Duijn CM, de Jong PT. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006;296(3):301\u20139. https:\/\/doi.org\/10.1001\/jama.296.3.301.","journal-title":"JAMA"},{"issue":"1","key":"2246_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1167\/iovs.09-4135","volume":"51","author":"I Kaur","year":"2010","unstructured":"Kaur I, Katta S, Reddy RK, Narayanan R, Mathai A, Majji AB, Chakrabarti S. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51(1):59\u201363. https:\/\/doi.org\/10.1167\/iovs.09-4135.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2246_CR30","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1007\/s00018-021-03796-9","volume":"78","author":"A Armento","year":"2021","unstructured":"Armento A, Ueffing M, Clark SJ. The complement system in age-related macular degeneration. Cell Mol Life Sci. 2021;78(10):4487\u2013505. https:\/\/doi.org\/10.1007\/s00018-021-03796-9.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2246_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ejhg.2009.113","volume":"18","author":"S Ennis","year":"2010","unstructured":"Ennis S, Gibson J, Cree AJ, Collins A, Lotery AJ. Support for the involvement of complement factor I in age-related macular degeneration. Eur J Hum Genet. 2010;18(1):15\u20136. https:\/\/doi.org\/10.1038\/ejhg.2009.113.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"2246_CR32","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1167\/iovs.14-15733","volume":"56","author":"M Gliem","year":"2015","unstructured":"Gliem M, Muller PL, Mangold E, Holz FG, Bolz HJ, Stohr H, Weber BH, Charbel Issa P. Sorsby fundus dystrophy: novel mutations, novel phenotypic characteristics, and treatment outcomes. Invest Ophthalmol Vis Sci. 2015;56(4):2664\u201376. https:\/\/doi.org\/10.1167\/iovs.14-15733.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"16","key":"2246_CR33","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1073\/pnas.0912019107","volume":"107","author":"BM Neale","year":"2010","unstructured":"Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA Jr., Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon JM. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107(16):7395\u2013400. https:\/\/doi.org\/10.1073\/pnas.0912019107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9652","key":"2246_CR34","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/S0140-6736(08)61348-3","volume":"372","author":"S Ennis","year":"2008","unstructured":"Ennis S, Jomary C, Mullins R, Cree A, Chen X, MacLeod A, Jones S, Collins A, Stone E, Lotery A. Association between the SERPING1 gene and age-related macular degeneration: a two-stage case\u2013control study. Lancet. 2008;372(9652):1828\u201334.","journal-title":"Lancet"},{"issue":"7","key":"2246_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/life11070635","volume":"11","author":"ML Hu","year":"2021","unstructured":"Hu ML, Quinn J, Xue K. Interactions between Apolipoprotein E metabolism and retinal inflammation in age-related macular degeneration. Life. 2021;11(7):635.","journal-title":"Life"},{"issue":"7","key":"2246_CR36","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1167\/iovs.05-1446","volume":"47","author":"CM Li","year":"2006","unstructured":"Li CM, Clark ME, Chimento MF, Curcio CA. Apolipoprotein localization in isolated Drusen and retinal Apolipoprotein gene expression. Invest Ophthalmol Vis Sci. 2006;47(7):3119\u201328. https:\/\/doi.org\/10.1167\/iovs.05-1446.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2246_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/s0002-9394(00)00961-2","volume":"131","author":"DH Anderson","year":"2001","unstructured":"Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, Hageman GS, Johnson LV. Local cellular sources of Apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of Drusen formation. Am J Ophthalmol. 2001;131(6):767\u201381. https:\/\/doi.org\/10.1016\/s0002-9394(00)00961-2.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2246_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2005.12.012","volume":"186","author":"G Eiriksdottir","year":"2006","unstructured":"Eiriksdottir G, Aspelund T, Bjarnadottir K, Olafsdottir E, Launer LJ, Harris TB, Gudnason V. Apolipoprotein E genotype and Statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik study. Atherosclerosis. 2006;186(1):222\u20134.","journal-title":"Atherosclerosis"},{"issue":"12","key":"2246_CR39","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1093\/hmg\/ddq129","volume":"19","author":"NV Strunnikova","year":"2010","unstructured":"Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, Sergeev Y, Chen W, Edwards AO, Stambolian D, Abecasis G, Swaroop A, Munson PJ, Miller SS. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum Mol Genet. 2010;19(12):2468\u201386. https:\/\/doi.org\/10.1093\/hmg\/ddq129.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2246_CR40","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1248\/bpb.b19-00858","volume":"43","author":"R Fukuda","year":"2020","unstructured":"Fukuda R, Murakami T. Potential of Lipoprotein-Based nanoparticulate formulations for the treatment of eye diseases. Biol Pharm Bull. 2020;43(4):596\u2013607. https:\/\/doi.org\/10.1248\/bpb.b19-00858.","journal-title":"Biol Pharm Bull"},{"key":"2246_CR41","unstructured":"[Available from: https:\/\/www.ebi.ac.uk\/gwas\/"},{"issue":"6","key":"2246_CR42","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ng.3546","volume":"48","author":"L Huang","year":"2016","unstructured":"Huang L, Zhang H, Cheng CY, Wen F, Tam PO, Zhao P, Chen H, Li Z, Chen L, Tai Z, Yamashiro K, Deng S, Zhu X, Chen W, Cai L, Lu F, Li Y, Cheung CM, Shi Y, Miyake M, Lin Y, Gong B, Liu X, Sim KS, Yang J, Mori K, Zhang X, Cackett PD, Tsujikawa M, Nishida K, Hao F, Ma S, Lin H, Cheng J, Fei P, Lai TY, Tang S, Laude A, Inoue S, Yeo IY, Sakurada Y, Zhou Y, Iijima H, Honda S, Lei C, Zhang L, Zheng H, Jiang D, Zhu X, Wong TY, Khor CC, Pang CP, Yoshimura N, Yang Z. A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy. Nat Genet. 2016;48(6):640\u20137. https:\/\/doi.org\/10.1038\/ng.3546.","journal-title":"Nat Genet"},{"issue":"2","key":"2246_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00251-004-0660-7","volume":"56","author":"J Esparza-Gordillo","year":"2004","unstructured":"Esparza-Gordillo J, Soria JM, Buil A, Almasy L, Blangero J, Fontcuberta J, Rodriguez de Cordoba S. Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics. 2004;56(2):77\u201382. https:\/\/doi.org\/10.1007\/s00251-004-0660-7.","journal-title":"Immunogenetics"},{"issue":"1","key":"2246_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archopht.125.1.49","volume":"125","author":"MM DeAngelis","year":"2007","unstructured":"DeAngelis MM, Ji F, Kim IK, Adams S, Capone A Jr., Ott J, Miller JW, Dryja TP. Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch Ophthalmol. 2007;125(1):49\u201354. https:\/\/doi.org\/10.1001\/archopht.125.1.49.","journal-title":"Arch Ophthalmol"},{"key":"2246_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.12.004","volume":"40","author":"L Sobrin","year":"2014","unstructured":"Sobrin L, Seddon JM. Nature and nurture-genes and environment-predict onset and progression of macular degeneration. Prog Retin Eye Res. 2014;40:1\u201315.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"2246_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000094141","volume":"61","author":"JM Seddon","year":"2006","unstructured":"Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered. 2006;61(3):157\u201365. https:\/\/doi.org\/10.1159\/000094141.","journal-title":"Hum Hered"},{"issue":"5","key":"2246_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/aje\/kwn358","volume":"169","author":"JJ Wang","year":"2009","unstructured":"Wang JJ, Rochtchina E, Smith W, Klein R, Klein BE, Joshi T, Sivakumaran TA, Iyengar S, Mitchell P. Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort. Am J Epidemiol. 2009;169(5):633\u201341. https:\/\/doi.org\/10.1093\/aje\/kwn358.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2246_CR48","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archophthalmol.2011.141","volume":"129","author":"L Ho","year":"2011","unstructured":"Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, de Jong PT, Vingerling JR, Klaver CC. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol. 2011;129(6):758\u201366. https:\/\/doi.org\/10.1001\/archophthalmol.2011.141.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2246_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ophtha.2013.10.017","volume":"121","author":"JJ Wang","year":"2014","unstructured":"Wang JJ, Buitendijk GH, Rochtchina E, Lee KE, Klein BE, van Duijn CM, Flood VM, Meuer SM, Attia J, Myers C, Holliday EG, Tan AG, Smith WT, Iyengar SK, de Jong PT, Hofman A, Vingerling JR, Mitchell P, Klein R, Klaver CC. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations. Ophthalmology. 2014;121(3):667\u201375. https:\/\/doi.org\/10.1016\/j.ophtha.2013.10.017.","journal-title":"Ophthalmology"},{"issue":"8","key":"2246_CR50","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.ophtha.2009.11.020","volume":"117","author":"JM Seddon","year":"2010","unstructured":"Seddon JM, Gensler G, Rosner B, C-reactive protein. ARMS2\/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology. 2010;117(8):1560\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2009.11.020.","journal-title":"Ophthalmology"},{"issue":"3","key":"2246_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/ahg.12011","volume":"77","author":"AC Naj","year":"2013","unstructured":"Naj AC, Scott WK, Courtenay MD, Cade WH, Schwartz SG, Kovach JL, Agarwal A, Wang G, Haines JL, Pericak-Vance MA. Genetic factors in nonsmokers with age\u2010related macular degeneration revealed through genome\u2010wide gene\u2010environment interaction analysis. Ann Hum Genet. 2013;77(3):215\u201331.","journal-title":"Ann Hum Genet"},{"key":"2246_CR52","first-page":"941","volume":"11","author":"S Schmidt","year":"2005","unstructured":"Schmidt S, Haines JL, Postel EA, Agarwal A, Kwan SY, Gilbert JR, Pericak-Vance MA, Scott WK. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis. 2005;11:941\u20139.","journal-title":"Mol Vis"},{"key":"2246_CR53","doi-asserted-by":"publisher","unstructured":"Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C, Gorski M, Kim IK, Cho D, Zack D, Souied E, Scholl HP, Bala E, Lee KE, Hunter DJ, Sardell RJ, Mitchell P, Merriam JE, Cipriani V, Hoffman JD, Schick T, Lechanteur YT, Guymer RH, Johnson MP, Jiang Y, Stanton CM, Buitendijk GH, Zhan X, Kwong AM, Boleda A, Brooks M, Gieser L, Ratnapriya R, Branham KE, Foerster JR, Heckenlively JR, Othman MI, Vote BJ, Liang HH, Souzeau E, McAllister IL, Isaacs T, Hall J, Lake S, Mackey DA, Constable IJ, Craig JE, Kitchner TE, Yang Z, Su Z, Luo H, Chen D, Ouyang H, Flagg K, Lin D, Mao G, Ferreyra H, Stark K, von Strachwitz CN, Wolf A, Brandl C, Rudolph G, Olden M, Morrison MA, Morgan DJ, Schu M, Ahn J, Silvestri G, Tsironi EE, Park KH, Farrer LA, Orlin A, Brucker A, Li M, Curcio CA, Mohand-Said S, Sahel JA, Audo I, Benchaboune M, Cree AJ, Rennie CA, Goverdhan SV, Grunin M, Hagbi-Levi S, Campochiaro P, Katsanis N, Holz FG, Blond F, Blanche H, Deleuze JF, Igo RP Jr., Truitt B, Peachey NS, Meuer SM, Myers CE, Moore EL, Klein R, Hauser MA, Postel EA, Courtenay MD, Schwartz SG, Kovach JL, Scott WK, Liew G, Tan AG, Gopinath B, Merriam JC, Smith RT, Khan JC, Shahid H, Moore AT, McGrath JA, Laux R, Brantley MA Jr., Agarwal A, Ersoy L, Caramoy A, Langmann T, Saksens NT, de Jong EK, Hoyng CB, Cain MS, Richardson AJ, Martin TM, Blangero J, Weeks DE, Dhillon B, van Duijn CM, Doheny KF, Romm J, Klaver CC, Hayward C, Gorin MB, Klein ML, Baird PN, den Hollander AI, Fauser S, Yates JR, Allikmets R, Wang JJ, Schaumberg DA, Klein BE, Hagstrom SA, Chowers I, Lotery AJ, Leveillard T, Zhang K, Brilliant MH, Hewitt AW, Swaroop A, Chew EY, Pericak-Vance MA, DeAngelis M, Stambolian D, Haines JL, Iyengar SK, Weber BH, Abecasis GR, Heid IM. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134\u2013\u200943.https:\/\/doi.org\/10.1038\/ng.3448","DOI":"10.1038\/ng.3448"},{"key":"2246_CR54","doi-asserted-by":"publisher","unstructured":"Colijn JM, den Hollander AI, Demirkan A, Cougnard-Gregoire A, Verzijden T, Kersten E, Meester-Smoor MA, Merle BMJ, Papageorgiou G, Ahmad S, Mulder MT, Costa MA, Benlian P, Bertelsen G, Bron AM, Claes B, Creuzot-Garcher C, Erke C, Fauser MG, Foster S, Hammond PJ, Hense CJ, Hoyng HW, Khawaja CB, Korobelnik AP, Piermarocchi JF, Segato T, Silva R, Souied EH, Williams KM, van Duijn CM, Delcourt C, Klaver CCW, European Eye Epidemiology C. Increased High-Density lipoprotein levels associated with Age-Related macular degeneration: evidence from the EYE-RISK and European eye epidemiology consortia. Ophthalmology. 2019;126(3):393\u2013406. https:\/\/doi.org\/10.1016\/j.ophtha.2018.09.045. Consortium E-R.","DOI":"10.1016\/j.ophtha.2018.09.045"},{"key":"2246_CR55","doi-asserted-by":"publisher","first-page":"101781DOI","DOI":"10.1016\/j.redox.2020.101781","volume":"37","author":"LX Tan","year":"2020","unstructured":"Tan LX, Germer CJ, La Cunza N, Lakkaraju A. Complement activation, lipid metabolism, and mitochondrial injury: converging pathways in age-related macular degeneration. Redox Biol. 2020;37:101781DOI. https:\/\/doi.org\/10.1016\/j.redox.2020.101781.","journal-title":"Redox Biol"},{"key":"2246_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.preteyeres.2017.01.005","volume":"58","author":"KE Guziewicz","year":"2017","unstructured":"Guziewicz KE, Sinha D, Gomez NM, Zorych K, Dutrow EV, Dhingra A, Mullins RF, Stone EM, Gamm DM, Boesze-Battaglia K, Aguirre GD. Bestrophinopathy: an RPE-photoreceptor interface disease. Prog Retin Eye Res. 2017;58:70\u201388. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.01.005.","journal-title":"Prog Retin Eye Res"},{"key":"2246_CR57","doi-asserted-by":"publisher","first-page":"e45100","DOI":"10.7554\/eLife.45100","volume":"8","author":"F Storti","year":"2019","unstructured":"Storti F, Klee K, Todorova V, Steiner R, Othman A, van der Velde-Visser S, Samardzija M, Meneau I, Barben M, Karademir D, Pauzuolyte V, Boye SL, Blaser F, Ullmer C, Dunaief JL, Hornemann T, Rohrer L, den Hollander A, von Eckardstein A, Fingerle J, Maugeais C, Grimm C. Impaired ABCA1\/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration. Elife. 2019;8:e45100. https:\/\/doi.org\/10.7554\/eLife.45100.","journal-title":"Elife"},{"issue":"26","key":"2246_CR58","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1073\/pnas.0702504104","volume":"104","author":"A Lakkaraju","year":"2007","unstructured":"Lakkaraju A, Finnemann SC, Rodriguez-Boulan E. The Lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc Natl Acad Sci U S A. 2007;104(26):11026\u201331. https:\/\/doi.org\/10.1073\/pnas.0702504104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2246_CR59","doi-asserted-by":"publisher","first-page":"17352","DOI":"10.1038\/s41598-017-17402-1","volume":"7","author":"DMG Anderson","year":"2017","unstructured":"Anderson DMG, Ablonczy Z, Koutalos Y, Hanneken AM, Spraggins JM, Calcutt MW, Crouch RK, Caprioli RM, Schey KL. Bis(monoacylglycero)phosphate lipids in the retinal pigment epithelium implicate lysosomal\/endosomal dysfunction in a model of Stargardt disease and human retinas. Sci Rep. 2017;7(1):17352. https:\/\/doi.org\/10.1038\/s41598-017-17402-1.","journal-title":"Sci Rep"},{"issue":"1","key":"2246_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1091\/mbc.E14-05-1028","volume":"26","author":"KA Toops","year":"2015","unstructured":"Toops KA, Tan LX, Jiang Z, Radu RA, Lakkaraju A. Cholesterol-mediated activation of acid Sphingomyelinase disrupts autophagy in the retinal pigment epithelium. Mol Biol Cell. 2015;26(1):1\u201314. https:\/\/doi.org\/10.1091\/mbc.E14-05-1028.","journal-title":"Mol Biol Cell"},{"issue":"36","key":"2246_CR61","doi-asserted-by":"publisher","first-page":"9014","DOI":"10.1073\/pnas.1805039115","volume":"115","author":"G Kaur","year":"2018","unstructured":"Kaur G, Tan LX, Rathnasamy G, La Cunza N, Germer CJ, Toops KA, Fernandes M, Blenkinsop TA, Lakkaraju A. Aberrant early endosome biogenesis mediates complement activation in the retinal pigment epithelium in models of macular degeneration. Proc Natl Acad Sci U S A. 2018;115(36):9014\u20139. https:\/\/doi.org\/10.1073\/pnas.1805039115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"2246_CR62","doi-asserted-by":"publisher","first-page":"8789","DOI":"10.1073\/pnas.1523061113","volume":"113","author":"LX Tan","year":"2016","unstructured":"Tan LX, Toops KA, Lakkaraju A. Protective responses to sublytic complement in the retinal pigment epithelium. Proc Natl Acad Sci U S A. 2016;113(31):8789\u201394. https:\/\/doi.org\/10.1073\/pnas.1523061113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2246_CR63","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fncel.2019.00246","volume":"13","author":"MV Sim\u00f3n","year":"2019","unstructured":"Sim\u00f3n MV, Prado Spalm FH, Vera MS, Rotstein NP. Sphingolipids as emerging mediators in retina degeneration. Front Cell Neurosci. 2019;13:246.","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"2246_CR64","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.2337\/db10-0550","volume":"60","author":"M Opreanu","year":"2011","unstructured":"Opreanu M, Tikhonenko M, Bozack S, Lydic TA, Reid GE, McSorley KM, Sochacki A, Perez GI, Esselman WJ, Kern T, Kolesnick R, Grant MB, Busik JV. The unconventional role of acid Sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models. Diabetes. 2011;60(9):2370\u20138. https:\/\/doi.org\/10.2337\/db10-0550.","journal-title":"Diabetes"},{"issue":"6","key":"2246_CR65","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1194\/jlr.M035048","volume":"54","author":"H Chen","year":"2013","unstructured":"Chen H, Tran JA, Eckerd A, Huynh TP, Elliott MH, Brush RS, Mandal NA. Inhibition of de Novo ceramide biosynthesis by FTY720 protects rat retina from light-induced degeneration. J Lipid Res. 2013;54(6):1616\u201329. https:\/\/doi.org\/10.1194\/jlr.M035048.","journal-title":"J Lipid Res"},{"issue":"3","key":"2246_CR66","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1194\/jlr.M044990","volume":"55","author":"KAZ Berry","year":"2014","unstructured":"Berry KAZ, Gordon WC, Murphy RC, Bazan NG. Spatial organization of lipids in the human retina and optic nerve by MALDI imaging mass spectrometry [S]. J Lipid Res. 2014;55(3):504\u201315.","journal-title":"J Lipid Res"},{"issue":"13","key":"2246_CR67","first-page":"5234","volume":"55","author":"WC Gordon","year":"2014","unstructured":"Gordon WC, Berry KAZ, Murphy RC, Bazan NG. MALDI imaging mass spectrometry of lipids in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2014;55(13):5234.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"2246_CR68","doi-asserted-by":"publisher","first-page":"e0200739","DOI":"10.1371\/journal.pone.0200739","volume":"13","author":"LM Pujol-Lereis","year":"2018","unstructured":"Pujol-Lereis LM, Liebisch G, Schick T, Lin Y, Grassmann F, Uchida K, Zipfel PF, Fauser S, Skerka C, Weber BHF. Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration. PLoS ONE. 2018;13(8):e0200739. https:\/\/doi.org\/10.1371\/journal.pone.0200739.","journal-title":"PLoS ONE"},{"key":"2246_CR69","doi-asserted-by":"publisher","first-page":"100846","DOI":"10.1016\/j.preteyeres.2020.100846","volume":"78","author":"A Lakkaraju","year":"2020","unstructured":"Lakkaraju A, Umapathy A, Tan LX, Daniele L, Philp NJ, Boesze-Battaglia K, Williams DS. The cell biology of the retinal pigment epithelium. Prog Retin Eye Res. 2020;78:100846. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100846.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"2246_CR70","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/15548627.2015.1041699","volume":"11","author":"J Yao","year":"2015","unstructured":"Yao J, Jia L, Khan N, Lin C, Mitter SK, Boulton ME, Dunaief JL, Klionsky DJ, Guan JL, Thompson DA, Zacks DN. Deletion of autophagy inducer RB1CC1 results in degeneration of the retinal pigment epithelium. Autophagy. 2015;11(6):939\u201353. https:\/\/doi.org\/10.1080\/15548627.2015.1041699.","journal-title":"Autophagy"},{"key":"2246_CR71","first-page":"228","volume":"23","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Cross SD, Stanton JB, Marmorstein AD, Le YZ, Marmorstein LY. Early AMD-like defects in the RPE and retinal degeneration in aged mice with RPE-specific deletion of Atg5 or Atg7. Mol Vis. 2017;23:228\u201341.","journal-title":"Mol Vis"},{"issue":"11","key":"2246_CR72","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.4161\/auto.36184","volume":"10","author":"SK Mitter","year":"2014","unstructured":"Mitter SK, Song C, Qi X, Mao H, Rao H, Akin D, Lewin A, Grant M, Dunn W Jr, Ding J. Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy. 2014;10(11):1989\u20132005.","journal-title":"Autophagy"},{"issue":"1","key":"2246_CR73","doi-asserted-by":"publisher","first-page":"e2537","DOI":"10.1038\/cddis.2016.453","volume":"8","author":"N Golestaneh","year":"2018","unstructured":"Golestaneh N, Chu Y, Xiao Y-Y, Stoleru GL, Theos AC. Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration. Cell Death Dis. 2018;8(1):e2537\u2013e.","journal-title":"Cell Death Dis"},{"issue":"16","key":"2246_CR74","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1001\/jama.297.16.1793","volume":"297","author":"JM Seddon","year":"2007","unstructured":"Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, Klein ML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007;297(16):1793\u2013800. https:\/\/doi.org\/10.1001\/jama.297.16.1793.","journal-title":"JAMA"},{"issue":"1","key":"2246_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/archopht.125.1.55","volume":"125","author":"DA Schaumberg","year":"2007","unstructured":"Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol. 2007;125(1):55\u201362. https:\/\/doi.org\/10.1001\/archopht.125.1.55.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"2246_CR76","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ophtha.2006.08.054","volume":"114","author":"WK Scott","year":"2007","unstructured":"Scott WK, Schmidt S, Hauser MA, Gallins P, Schnetz-Boutaud N, Spencer KL, Gilbert JR, Agarwal A, Postel EA, Haines JL, Pericak-Vance MA. Independent effects of complement factor H Y402H polymorphism and cigarette smoking on risk of age-related macular degeneration. Ophthalmology. 2007;114(6):1151\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.054.","journal-title":"Ophthalmology"},{"issue":"4","key":"2246_CR77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/ars.2017.7084","volume":"29","author":"KB Ebrahimi","year":"2018","unstructured":"Ebrahimi KB, Cano M, Rhee J, Datta S, Wang L, Handa JT. Oxidative stress induces an interactive decline in Wnt and Nrf2 signaling in degenerating retinal pigment epithelium. Antioxid Redox Signal. 2018;29(4):389\u2013407. https:\/\/doi.org\/10.1089\/ars.2017.7084.","journal-title":"Antioxid Redox Signal"},{"issue":"25","key":"2246_CR78","doi-asserted-by":"publisher","first-page":"16939","DOI":"10.1074\/jbc.M808166200","volume":"284","author":"JM Thurman","year":"2009","unstructured":"Thurman JM, Renner B, Kunchithapautham K, Ferreira VP, Pangburn MK, Ablonczy Z, Tomlinson S, Holers VM, Rohrer B. Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. J Biol Chem. 2009;284(25):16939\u201347. https:\/\/doi.org\/10.1074\/jbc.M808166200.","journal-title":"J Biol Chem"},{"issue":"21","key":"2246_CR79","doi-asserted-by":"publisher","first-page":"14534","DOI":"10.1074\/jbc.M114.564674","volume":"289","author":"K Kunchithapautham","year":"2014","unstructured":"Kunchithapautham K, Atkinson C, Rohrer B. Smoke exposure causes Endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation. J Biol Chem. 2014;289(21):14534\u201346.","journal-title":"J Biol Chem"},{"issue":"5","key":"2246_CR80","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/path.4128","volume":"229","author":"KB Ebrahimi","year":"2013","unstructured":"Ebrahimi KB, Fijalkowski N, Cano M, Handa JT. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. J Pathol. 2013;229(5):729\u201342. https:\/\/doi.org\/10.1002\/path.4128.","journal-title":"J Pathol"},{"issue":"4","key":"2246_CR81","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.exer.2011.06.002","volume":"93","author":"SD Vogt","year":"2011","unstructured":"Vogt SD, Curcio CA, Wang L, Li C-M, McGwin G Jr, Medeiros NE, Philp NJ, Kimble JA, Read RW. Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. Exp Eye Res. 2011;93(4):413\u201323.","journal-title":"Exp Eye Res"},{"key":"2246_CR82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.exer.2016.01.018","volume":"145","author":"DA Ferrington","year":"2016","unstructured":"Ferrington DA, Kapphahn RJ, Leary MM, Atilano SR, Terluk MR, Karunadharma P, Chen GK, Ratnapriya R, Swaroop A, Montezuma SR, Kenney MC. Increased retinal MtDNA damage in the CFH variant associated with age-related macular degeneration. Exp Eye Res. 2016;145:269\u201377. https:\/\/doi.org\/10.1016\/j.exer.2016.01.018.","journal-title":"Exp Eye Res"},{"key":"2246_CR83","doi-asserted-by":"publisher","unstructured":"La Cunza N, Tan LX, Thamban T, Germer CJ, Rathnasamy G, Toops KA, Lakkaraju A. Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration. JCI Insight. 2021;6(9). https:\/\/doi.org\/10.1172\/jci.insight.142254.","DOI":"10.1172\/jci.insight.142254"},{"issue":"17","key":"2246_CR84","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1073\/pnas.1600474113","volume":"113","author":"JR Sparrow","year":"2016","unstructured":"Sparrow JR. Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics. Proc Natl Acad Sci U S A. 2016;113(17):4564\u20139. https:\/\/doi.org\/10.1073\/pnas.1600474113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"2246_CR85","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.1074\/jbc.RA118.002062","volume":"293","author":"B Racz","year":"2018","unstructured":"Racz B, Varadi A, Kong J, Allikmets R, Pearson PG, Johnson G, Cioffi CL, Petrukhin K. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle. J Biol Chem. 2018;293(29):11574\u201388.","journal-title":"J Biol Chem"},{"key":"2246_CR86","doi-asserted-by":"crossref","unstructured":"Charbel Issa P, Barnard AR, Herrmann P, Washington I, MacLaren RE. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proceedings of the National Academy of Sciences. 2015;112(27):8415-20.","DOI":"10.1073\/pnas.1506960112"},{"issue":"3","key":"2246_CR87","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/ICU.0000000000000657","volume":"31","author":"MJ Ammar","year":"2020","unstructured":"Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD. Age-related macular degeneration therapy: a review. Curr Opin Ophthalmol. 2020;31(3):215\u201321. https:\/\/doi.org\/10.1097\/ICU.0000000000000657.","journal-title":"Curr Opin Ophthalmol"},{"issue":"25","key":"2246_CR88","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1073\/pnas.1524774113","volume":"113","author":"K Ueda","year":"2016","unstructured":"Ueda K, Zhao J, Kim HJ, Sparrow JR. Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration. Proc Natl Acad Sci U S A. 2016;113(25):6904\u20139. https:\/\/doi.org\/10.1073\/pnas.1524774113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2246_CR89","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fphar.2018.00242","volume":"9","author":"W Lu","year":"2018","unstructured":"Lu W, Gomez NM, Lim JC, Guha S, O\u2019Brien-Jenkins A, Coffey EE, Campagno KE, McCaughey SA, Laties AM, Carlsson LG, Mitchell CH. The P2Y(12) receptor antagonist Ticagrelor reduces lysosomal pH and autofluorescence in retinal pigmented epithelial cells from the ABCA4(-\/-) mouse model of retinal degeneration. Front Pharmacol. 2018;9:242. https:\/\/doi.org\/10.3389\/fphar.2018.00242.","journal-title":"Front Pharmacol"},{"issue":"5","key":"2246_CR90","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stem.2016.12.015","volume":"20","author":"JS Saini","year":"2017","unstructured":"Saini JS, Corneo B, Miller JD, Kiehl TR, Wang Q, Boles NC, Blenkinsop TA, Stern JH, Temple S. Nicotinamide ameliorates disease phenotypes in a human iPSC model of Age-Related macular degeneration. Cell Stem Cell. 2017;20(5):635\u2013e477. https:\/\/doi.org\/10.1016\/j.stem.2016.12.015.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2246_CR91","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1038\/s41598-020-59244-4","volume":"10","author":"M Zhang","year":"2020","unstructured":"Zhang M, Jiang N, Chu Y, Postnikova O, Varghese R, Horvath A, Cheema AK, Golestaneh N. Dysregulated metabolic pathways in age-related macular degeneration. Sci Rep. 2020;10(1):2464. https:\/\/doi.org\/10.1038\/s41598-020-59244-4.","journal-title":"Sci Rep"},{"key":"2246_CR92","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.preteyeres.2018.04.006","volume":"67","author":"EM van Leeuwen","year":"2018","unstructured":"van Leeuwen EM, Emri E, Merle BMJ, Colijn JM, Kersten E, Cougnard-Gregoire A, Dammeier S, Meester-Smoor M, Pool FM, de Jong EK, Delcourt C, Rodrigez-Bocanegra E, Biarnes M, Luthert PJ, Ueffing M, Klaver CCW, Nogoceke E, den Hollander AI, Lengyel I. A new perspective on lipid research in age-related macular degeneration. Prog Retin Eye Res. 2018;67:56\u201386. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.04.006.","journal-title":"Prog Retin Eye Res"},{"issue":"13","key":"2246_CR93","doi-asserted-by":"publisher","first-page":"7766","DOI":"10.1167\/iovs.15-17035","volume":"56","author":"CC Paun","year":"2015","unstructured":"Paun CC, Ersoy L, Schick T, Groenewoud JM, Lechanteur YT, Fauser S, Hoyng CB, de Jong EK, den Hollander AI. Genetic variants and systemic complement activation levels are associated with serum lipoprotein levels in Age-Related macular degeneration. Invest Ophthalmol Vis Sci. 2015;56(13):7766\u201373. https:\/\/doi.org\/10.1167\/iovs.15-17035.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2246_CR94","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0002-9440(10)63836-9","volume":"162","author":"G Malek","year":"2003","unstructured":"Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA. Apolipoprotein B in cholesterol-containing Drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol. 2003;162(2):413\u201325. https:\/\/doi.org\/10.1016\/S0002-9440(10)63836-9.","journal-title":"Am J Pathol"},{"issue":"5","key":"2246_CR95","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.exer.2008.07.010","volume":"87","author":"M Rudolf","year":"2008","unstructured":"Rudolf M, Malek G, Messinger JD, Clark ME, Wang L, Curcio CA. Sub-retinal drusenoid deposits in human retina: organization and composition. Exp Eye Res. 2008;87(5):402\u20138. https:\/\/doi.org\/10.1016\/j.exer.2008.07.010.","journal-title":"Exp Eye Res"},{"issue":"7","key":"2246_CR96","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1167\/iovs.05-0034","volume":"46","author":"CM Li","year":"2005","unstructured":"Li CM, Chung BH, Presley JB, Malek G, Zhang X, Dashti N, Li L, Chen J, Bradley K, Kruth HS, Curcio CA. Lipoprotein-like particles and cholesteryl esters in human Bruch\u2019s membrane: initial characterization. Invest Ophthalmol Vis Sci. 2005;46(7):2576\u201386. https:\/\/doi.org\/10.1167\/iovs.05-0034.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2246_CR97","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318. https:\/\/doi.org\/10.1038\/s41582-019-0228-7.","journal-title":"Nat Rev Neurol"},{"key":"2246_CR98","doi-asserted-by":"publisher","first-page":"974361DOI","DOI":"10.4061\/2011\/974361","volume":"2011","author":"V Leduc","year":"2011","unstructured":"Leduc V, Domenger D, De Beaumont L, Lalonde D, Belanger-Jasmin S, Poirier J. Function and comorbidities of Apolipoprotein e in Alzheimer\u2019s disease. Int J Alzheimers Dis. 2011;2011:974361DOI. https:\/\/doi.org\/10.4061\/2011\/974361.","journal-title":"Int J Alzheimers Dis"},{"key":"2246_CR99","doi-asserted-by":"crossref","unstructured":"Toops KA, Tan LX, Lakkaraju A, Apolipoprotein. E isoforms and AMD: Springer; 2016.","DOI":"10.1007\/978-3-319-17121-0_1"},{"issue":"16","key":"2246_CR100","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, Van Duijn CM. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"5","key":"2246_CR101","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1167\/iovs.03-1253","volume":"45","author":"S Zareparsi","year":"2004","unstructured":"Zareparsi S, Reddick AC, Branham KE, Moore KB, Jessup L, Thoms S, Smith-Wheelock M, Yashar BM, Swaroop A. Association of Apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci. 2004;45(5):1306. https:\/\/doi.org\/10.1167\/iovs.03-1253.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"2246_CR102","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/humu.21577","volume":"32","author":"GJ McKay","year":"2011","unstructured":"McKay GJ, Patterson CC, Chakravarthy U, Dasari S, Klaver CC, Vingerling JR, Ho L, de Jong PT, Fletcher AE, Young IS, Seland JH, Rahu M, Soubrane G, Tomazzoli L, Topouzis F, Vioque J, Hingorani AD, Sofat R, Dean M, Sawitzke J, Seddon JM, Peter I, Webster AR, Moore AT, Yates JR, Cipriani V, Fritsche LG, Weber BH, Keilhauer CN, Lotery AJ, Ennis S, Klein ML, Francis PJ, Stambolian D, Orlin A, Gorin MB, Weeks DE, Kuo CL, Swaroop A, Othman M, Kanda A, Chen W, Abecasis GR, Wright AF, Hayward C, Baird PN, Guymer RH, Attia J, Thakkinstian A, Silvestri G. Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat. 2011;32(12):1407\u201316. https:\/\/doi.org\/10.1002\/humu.21577.","journal-title":"Hum Mutat"},{"issue":"1747","key":"2246_CR103","doi-asserted-by":"publisher","first-page":"20170193","DOI":"10.1098\/rstb.2017.0193","volume":"373","author":"RJ Wheeler","year":"2018","unstructured":"Wheeler RJ, Hyman AA. Controlling compartmentalization by non-membrane-bound organelles. Philos Trans R Soc Lond B Biol Sci. 2018;373(1747):20170193. https:\/\/doi.org\/10.1098\/rstb.2017.0193.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"2246_CR104","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","volume":"163","author":"A Molliex","year":"2015","unstructured":"Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163(1):123\u201333. https:\/\/doi.org\/10.1016\/j.cell.2015.09.015.","journal-title":"Cell"},{"issue":"1","key":"2246_CR105","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1038\/s41467-019-11262-1","volume":"10","author":"JT Handa","year":"2019","unstructured":"Handa JT, Bowes Rickman C, Dick AD, Gorin MB, Miller JW, Toth CA, Ueffing M, Zarbin M, Farrer LA. A systems biology approach towards Understanding and treating non-neovascular age-related macular degeneration. Nat Commun. 2019;10(1):3347. https:\/\/doi.org\/10.1038\/s41467-019-11262-1.","journal-title":"Nat Commun"},{"issue":"11","key":"2246_CR106","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.3390\/ijms19113688","volume":"19","author":"M Roizenblatt","year":"2018","unstructured":"Roizenblatt M, Naranjit N, Maia M, Gehlbach PL. The question of a role for Statins in Age-Related macular degeneration. Int J Mol Sci. 2018;19(11):3688. https:\/\/doi.org\/10.3390\/ijms19113688.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2246_CR107","doi-asserted-by":"publisher","first-page":"CD006927DOI","DOI":"10.1002\/14651858.CD006927.pub5","volume":"2016","author":"P Gehlbach","year":"2016","unstructured":"Gehlbach P, Li T, Hatef E. Statins for age-related macular degeneration. Cochrane Database Syst Rev. 2016;2016(8):CD006927DOI. https:\/\/doi.org\/10.1002\/14651858.CD006927.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"2246_CR108","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ebiom.2016.01.033","volume":"5","author":"DG Vavvas","year":"2016","unstructured":"Vavvas DG, Daniels AB, Kapsala ZG, Goldfarb JW, Ganotakis E, Loewenstein JI, Young LH, Gragoudas ES, Eliott D, Kim IK. Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive Statin treatment. EBioMedicine. 2016;5:198\u2013203.","journal-title":"EBioMedicine"},{"key":"2246_CR109","doi-asserted-by":"crossref","unstructured":"Choudhary M, Ismail EN, Yao P-L, Tayyari F, Radu RA, Nusinowitz S, Boulton ME, Apte RS, Ruberti JW, Handa JT. LXRs regulate features of age-related macular degeneration and May be a potential therapeutic target. JCI Insight. 2020;5(1).","DOI":"10.1172\/jci.insight.131928"},{"key":"2246_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.07.010","volume":"181","author":"MB Fessler","year":"2018","unstructured":"Fessler MB. The challenges and promise of targeting the liver X receptors for treatment of inflammatory disease. Pharmacol Ther. 2018;181:1\u201312. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.07.010.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2246_CR111","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19(3):175\u201391.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"2246_CR112","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1167\/iovs.16-19717","volume":"57","author":"J Fan","year":"2016","unstructured":"Fan J, Wu BX, Crosson CE. Suppression of acid Sphingomyelinase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2016;57(10):4476\u201384. https:\/\/doi.org\/10.1167\/iovs.16-19717.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2246_CR113","doi-asserted-by":"crossref","unstructured":"Simon MV, Basu SK, Qaladize B, Grambergs R, Rotstein NP, Mandal N. Sphingolipids as critical players in retinal physiology and pathology. J Lipid Res. 2021;62.","DOI":"10.1194\/jlr.TR120000972"},{"issue":"43","key":"2246_CR114","doi-asserted-by":"publisher","first-page":"18706","DOI":"10.1073\/pnas.1007644107","volume":"107","author":"E Strettoi","year":"2010","unstructured":"Strettoi E, Gargini C, Novelli E, Sala G, Piano I, Gasco P, Ghidoni R. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2010;107(43):18706\u201311. https:\/\/doi.org\/10.1073\/pnas.1007644107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2246_CR115","doi-asserted-by":"publisher","first-page":"e23852","DOI":"10.1371\/journal.pone.0023852","volume":"6","author":"J Kornhuber","year":"2011","unstructured":"Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Muhle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P. Identification of novel functional inhibitors of acid Sphingomyelinase. PLoS ONE. 2011;6(8):e23852. https:\/\/doi.org\/10.1371\/journal.pone.0023852.","journal-title":"PLoS ONE"},{"issue":"6","key":"2246_CR116","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tips.2014.04.003","volume":"35","author":"J Kornhuber","year":"2014","unstructured":"Kornhuber J, M\u00fcller CP, Becker KA, Reichel M, Gulbins E. The ceramide system as a novel antidepressant target. Trends Pharmacol Sci. 2014;35(6):293\u2013304.","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"2246_CR117","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.ophtha.2003.10.024","volume":"111","author":"R van Leeuwen","year":"2004","unstructured":"van Leeuwen R, Tomany SC, Wang JJ, Klein R, Mitchell P, Hofman A, Klein BE, Vingerling JR, Cumming RG, de Jong PT. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology. 2004;111(6):1169\u201375.","journal-title":"Ophthalmology"},{"issue":"9","key":"2246_CR118","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/archopht.119.9.1354","volume":"119","author":"R Klein","year":"2001","unstructured":"Klein R, Klein BE, Jensen SC, Cruickshanks KJ, Lee KE, Danforth LG, Tomany SC. Medication use and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Arch Ophthalmol. 2001;119(9):1354\u20139. https:\/\/doi.org\/10.1001\/archopht.119.9.1354.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2246_CR119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuron.2018.09.010","volume":"100","author":"MH Park","year":"2018","unstructured":"Park MH, Lee JY, Park KH, Jung IK, Kim K-T, Lee Y-S, Ryu H-H, Jeong Y, Kang M, Schwaninger M. Vascular and neurogenic rejuvenation in aging mice by modulation of ASM. Neuron. 2018;100(1):167\u201382. e9.","journal-title":"Neuron"},{"issue":"2","key":"2246_CR120","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tem.2018.11.003","volume":"30","author":"G Lin","year":"2019","unstructured":"Lin G, Wang L, Marcogliese PC, Bellen HJ. Sphingolipids in the pathogenesis of Parkinson\u2019s disease and parkinsonism. Trends Endocrinol Metab. 2019;30(2):106\u201317. https:\/\/doi.org\/10.1016\/j.tem.2018.11.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"2246_CR121","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/bjophthalmol-2020-316195","volume":"105","author":"TAC de Guimaraes","year":"2021","unstructured":"de Guimaraes TAC, Georgiou M, Bainbridge JW, Michaelides M. Gene therapy for neovascular age-related macular degeneration: rationale, clinical trials and future directions. Br J Ophthalmol. 2021;105(2):151\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"2246_CR122","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1089\/hum.1997.8.10-1275","volume":"8","author":"N Morral","year":"1997","unstructured":"Morral N, O\u2019Neal W, Zhou H, Langston C, Beaudet A. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum Gene Ther. 1997;8(10):1275\u201386. https:\/\/doi.org\/10.1089\/hum.1997.8.10-1275.","journal-title":"Hum Gene Ther"},{"issue":"12","key":"2246_CR123","doi-asserted-by":"publisher","first-page":"8934","DOI":"10.1128\/JVI.70.12.8934-8943.1996","volume":"70","author":"GP Gao","year":"1996","unstructured":"Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol. 1996;70(12):8934\u201343. https:\/\/doi.org\/10.1128\/JVI.70.12.8934-8943.1996.","journal-title":"J Virol"},{"issue":"22","key":"2246_CR124","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","volume":"96","author":"N Morral","year":"1999","unstructured":"Morral N, O\u2019Neal W, Rice K, Leland M, Kaplan J, Piedra PA, Zhou H, Parks RJ, Velji R, Aguilar-Cordova E, Wadsworth S, Graham FL, Kochanek S, Carey KD, Beaudet AL. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci U S A. 1999;96(22):12816\u201321. https:\/\/doi.org\/10.1073\/pnas.96.22.12816.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2246_CR125","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1089\/hum.1998.9.18-2709","volume":"9","author":"N Morral","year":"1998","unstructured":"Morral N, Parks RJ, Zhou H, Langston C, Schiedner G, Quinones J, Graham FL, Kochanek S, Beaudet AL. High doses of a helper-dependent adenoviral vector yield Supraphysiological levels of \u03b1 1-antitrypsin with negligible toxicity. Hum Gene Ther. 1998;9(18):2709\u201316.","journal-title":"Hum Gene Ther"},{"key":"2246_CR126","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","volume":"24","author":"L Lisowski","year":"2015","unstructured":"Lisowski L, Tay SS, Alexander IE. Adeno-associated virus serotypes for gene therapeutics. Curr Opin Pharmacol. 2015;24:59\u201367. https:\/\/doi.org\/10.1016\/j.coph.2015.07.006.","journal-title":"Curr Opin Pharmacol"},{"key":"2246_CR127","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coviro.2016.07.010","volume":"21","author":"EM Everson","year":"2016","unstructured":"Everson EM, Trobridge GD. Retroviral vector interactions with hematopoietic cells. Curr Opin Virol. 2016;21:41\u20136. https:\/\/doi.org\/10.1016\/j.coviro.2016.07.010.","journal-title":"Curr Opin Virol"},{"issue":"15","key":"2246_CR128","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1089\/104303401753153947","volume":"12","author":"M Kumar","year":"2001","unstructured":"Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther. 2001;12(15):1893\u2013905. https:\/\/doi.org\/10.1089\/104303401753153947.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"2246_CR129","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molmed.2016.02.002","volume":"22","author":"C Booth","year":"2016","unstructured":"Booth C, Gaspar HB, Thrasher AJ. Treating immunodeficiency through HSC gene therapy. Trends Mol Med. 2016;22(4):317\u201327.","journal-title":"Trends Mol Med"},{"issue":"12","key":"2246_CR130","doi-asserted-by":"publisher","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","volume":"72","author":"R Zufferey","year":"1998","unstructured":"Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol. 1998;72(12):9873\u201380. https:\/\/doi.org\/10.1128\/JVI.72.12.9873-9880.1998.","journal-title":"J Virol"},{"issue":"1","key":"2246_CR131","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines2010014","volume":"2","author":"A Shaw","year":"2014","unstructured":"Shaw A, Cornetta K. Design and potential of Non-Integrating lentiviral vectors. Biomedicines. 2014;2(1):14\u201335. https:\/\/doi.org\/10.3390\/biomedicines2010014.","journal-title":"Biomedicines"},{"key":"2246_CR132","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-61779-370-7_8","volume":"807","author":"K Stieger","year":"2011","unstructured":"Stieger K, Cronin T, Bennett J, Rolling F. Adeno-associated virus mediated gene therapy for retinal degenerative diseases. Methods Mol Biol. 2011;807:179\u2013218. https:\/\/doi.org\/10.1007\/978-1-61779-370-7_8.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2246_CR133","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.visres.2007.07.027","volume":"48","author":"EM Surace","year":"2008","unstructured":"Surace EM, Auricchio A. Versatility of AAV vectors for retinal gene transfer. Vis Res. 2008;48(3):353\u20139. https:\/\/doi.org\/10.1016\/j.visres.2007.07.027.","journal-title":"Vis Res"},{"issue":"6","key":"2246_CR134","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/rmv.1762","volume":"23","author":"S Hareendran","year":"2013","unstructured":"Hareendran S, Balakrishnan B, Sen D, Kumar S, Srivastava A, Jayandharan GR. Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them. Rev Med Virol. 2013;23(6):399\u2013413.","journal-title":"Rev Med Virol"},{"issue":"12","key":"2246_CR135","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1016\/j.ymthe.2024.10.017","volume":"32","author":"JH Wang","year":"2024","unstructured":"Wang JH, Zhan W, Gallagher TL, Gao G. Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: A comprehensive review. Mol Ther. 2024;32(12):4185\u2013207. https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.017.","journal-title":"Mol Ther"},{"issue":"3","key":"2246_CR136","doi-asserted-by":"publisher","first-page":"e1607","DOI":"10.1002\/ctm2.1607","volume":"14","author":"VV Kolesnik","year":"2024","unstructured":"Kolesnik VV, Nurtdinov RF, Oloruntimehin ES, Karabelsky AV, Malogolovkin AS. Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes. Clin Transl Med. 2024;14(3):e1607. https:\/\/doi.org\/10.1002\/ctm2.1607.","journal-title":"Clin Transl Med"},{"issue":"12","key":"2246_CR137","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3390\/pharmaceutics13122035","volume":"13","author":"B Yang","year":"2021","unstructured":"Yang B, Li G, Liu J, Li X, Zhang S, Sun F, Liu W. Nanotechnology for Age-Related macular degeneration. Pharmaceutics. 2021;13(12):2035. https:\/\/doi.org\/10.3390\/pharmaceutics13122035.","journal-title":"Pharmaceutics"},{"issue":"9","key":"2246_CR138","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn JD, Smith AR, Patel MC, Shaw L, Youniss MR, van Heteren J, Dirstine T, Ciullo C, Lescarbeau R, Seitzer J, Shah RR, Shah A, Ling D, Growe J, Pink M, Rohde E, Wood KM, Salomon WE, Harrington WF, Dombrowski C, Strapps WR, Chang Y, Morrissey DV. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 2018;22(9):2227\u201335. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.014.","journal-title":"Cell Rep"},{"issue":"3","key":"2246_CR139","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1021\/acs.bioconjchem.8b00856","volume":"30","author":"D Sun","year":"2018","unstructured":"Sun D, Sun Z, Jiang H, Vaidya AM, Xin R, Ayat NR, Schilb AL, Qiao PL, Han Z, Naderi A. Synthesis and evaluation of pH-sensitive multifunctional lipids for efficient delivery of CRISPR\/Cas9 in gene editing. Bioconjug Chem. 2018;30(3):667\u201378.","journal-title":"Bioconjug Chem"},{"issue":"2","key":"2246_CR140","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/jop.2012.0128","volume":"29","author":"A del Pozo-Rodr\u00edguez","year":"2013","unstructured":"del Pozo-Rodr\u00edguez A, Delgado D, Gasc\u00f3n AR, Solin\u00eds M\u00c1. Lipid nanoparticles as drug\/gene delivery systems to the retina. J Ocul Pharmacol Ther. 2013;29(2):173\u201388.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"2246_CR141","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/jfb6020379","volume":"6","author":"Y Wang","year":"2015","unstructured":"Wang Y, Rajala A, Rajala RV. Lipid nanoparticles for ocular gene delivery. J Funct Biomater. 2015;6(2):379\u201394. https:\/\/doi.org\/10.3390\/jfb6020379.","journal-title":"J Funct Biomater"},{"issue":"1","key":"2246_CR142","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: a review of the challenges and approaches. Drug Deliv. 2018;25(1):1234\u201357. https:\/\/doi.org\/10.1080\/10717544.2018.1474964.","journal-title":"Drug Deliv"},{"issue":"2","key":"2246_CR143","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1021\/pr400751k","volume":"13","author":"G-Y Kang","year":"2014","unstructured":"Kang G-Y, Bang JY, Choi AJ, Yoon J, Lee W-C, Choi S, Yoon S, Kim HC, Baek J-H, Park HS. Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration. J Proteome Res. 2014;13(2):581\u201395.","journal-title":"J Proteome Res"},{"issue":"13","key":"2246_CR144","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.yexcr.2013.05.005","volume":"319","author":"L Biasutto","year":"2013","unstructured":"Biasutto L, Chiechi A, Couch R, Liotta LA, Espina V. Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress. Exp Cell Res. 2013;319(13):2113\u201323. https:\/\/doi.org\/10.1016\/j.yexcr.2013.05.005.","journal-title":"Exp Cell Res"},{"issue":"39","key":"2246_CR145","doi-asserted-by":"publisher","first-page":"28058","DOI":"10.1074\/jbc.M113.470765","volume":"288","author":"AR Hajrasouliha","year":"2013","unstructured":"Hajrasouliha AR, Jiang G, Lu Q, Lu H, Kaplan HJ, Zhang H-G, Shao H. Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization. J Biol Chem. 2013;288(39):28058\u201367.","journal-title":"J Biol Chem"},{"issue":"24","key":"2246_CR146","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1002\/cbic.202100359","volume":"22","author":"L Duan","year":"2021","unstructured":"Duan L, Ouyang K, Wang J, Xu L, Xu X, Wen C, Xie Y, Liang Y, Xia J. Exosomes as targeted delivery platform of CRISPR\/Cas9 for therapeutic genome editing. ChemBioChem. 2021;22(24):3360\u20138.","journal-title":"ChemBioChem"},{"issue":"10","key":"2246_CR147","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1021\/acs.molpharmaceut.5b00364","volume":"12","author":"TN Lamichhane","year":"2015","unstructured":"Lamichhane TN, Raiker RS, Jay SM. Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm. 2015;12(10):3650\u20137.","journal-title":"Mol Pharm"},{"key":"2246_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.004","volume":"48","author":"H Nazari","year":"2015","unstructured":"Nazari H, Zhang L, Zhu D, Chader GJ, Falabella P, Stefanini F, Rowland T, Clegg DO, Kashani AH, Hinton DR, Humayun MS. Stem cell based therapies for age-related macular degeneration: the promises and the challenges. Prog Retin Eye Res. 2015;48:1\u201339. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.004.","journal-title":"Prog Retin Eye Res"},{"issue":"9967","key":"2246_CR149","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","volume":"385","author":"SD Schwartz","year":"2015","unstructured":"Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: follow-up of two open-label phase 1\/2 studies. Lancet. 2015;385(9967):509\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(14)61376-3.","journal-title":"Lancet"},{"issue":"3","key":"2246_CR150","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/clo.2006.8.189","volume":"8","author":"RD Lund","year":"2006","unstructured":"Lund RD, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B, Girman S, Bischoff N, Sauve Y, Lanza R. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells. 2006;8(3):189\u201399. https:\/\/doi.org\/10.1089\/clo.2006.8.189.","journal-title":"Cloning Stem Cells"},{"issue":"3","key":"2246_CR151","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1634\/stemcells.2006-0308","volume":"25","author":"RD Lund","year":"2007","unstructured":"Lund RD, Wang S, Lu B, Girman S, Holmes T, Sauve Y, Messina DJ, Harris IR, Kihm AJ, Harmon AM, Chin FY, Gosiewska A, Mistry SK. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells. 2007;25(3):602\u201311. https:\/\/doi.org\/10.1634\/stemcells.2006-0308.","journal-title":"Stem Cells"},{"issue":"9","key":"2246_CR152","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/stem.149","volume":"27","author":"B Lu","year":"2009","unstructured":"Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009;27(9):2126\u201335. https:\/\/doi.org\/10.1002\/stem.149.","journal-title":"Stem Cells"},{"issue":"2","key":"2246_CR153","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.stemcr.2013.12.007","volume":"2","author":"H Kamao","year":"2014","unstructured":"Kamao H, Mandai M, Okamoto S, Sakai N, Suga A, Sugita S, Kiryu J, Takahashi M. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2014;2(2):205\u201318. https:\/\/doi.org\/10.1016\/j.stemcr.2013.12.007.","journal-title":"Stem Cell Rep"},{"key":"2246_CR154","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000357375","volume":"53","author":"B Lu","year":"2014","unstructured":"Lu B, Tai YC, Humayun MS. Microdevice-based cell therapy for age-related macular degeneration. Dev Ophthalmol. 2014;53:155\u201366. https:\/\/doi.org\/10.1159\/000357375.","journal-title":"Dev Ophthalmol"},{"issue":"1","key":"2246_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bi901263m","volume":"49","author":"SM Mooney","year":"2010","unstructured":"Mooney SM, Grande JP, Salisbury JL, Janknecht R. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry. 2010;49(1):1\u201310. https:\/\/doi.org\/10.1021\/bi901263m.","journal-title":"Biochemistry"},{"issue":"6199","key":"2246_CR156","doi-asserted-by":"publisher","first-page":"1247391","DOI":"10.1126\/science.1247391","volume":"345","author":"IJ Fox","year":"2014","unstructured":"Fox IJ, Daley GQ, Goldman SA, Huard J, Kamp TJ, Trucco M. Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science. 2014;345(6199):1247391. https:\/\/doi.org\/10.1126\/science.1247391.","journal-title":"Science"},{"issue":"7","key":"2246_CR157","first-page":"5317","volume":"65","author":"X Ke","year":"2024","unstructured":"Ke X, Wu Y, Yu X, Yang S, Luo S, Qing X, Ingerman A, Oughton A, Shearn SP, Zheng Q. Combined complement inhibitors and Anti-VEGF therapy for the treatment of dry Age-Related macular degeneration (AMD). Investig Ophthalmol Vis Sci. 2024;65(7):5317.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"14","key":"2246_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.65.14.1","volume":"65","author":"MA Calton","year":"2024","unstructured":"Calton MA, Croze RH, Burns C, Beliakoff G, Vazin T, Szymanski P, Schmitt C, Klein A, Leong M, Quezada M, Holt J, Bolender G, Barglow K, Khoday D, Mason T, Delaria K, Hassanipour M, Kotterman M, Khanani AM, Schaffer D, Francis P, Kirn D. Design and characterization of a novel intravitreal Dual-Transgene genetic medicine for neovascular retinopathies. Invest Ophthalmol Vis Sci. 2024;65(14):1. https:\/\/doi.org\/10.1167\/iovs.65.14.1.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2246_CR159","doi-asserted-by":"crossref","unstructured":"Kotterman M, Beliakoff G, Croze R, Vazin T, Schmitt C, Szymanski P, Leong M, Quezada M, Holt J, Barglow K. Directed evolution of AAV targeting primate retina by intravitreal injection identifies R100, a variant demonstrating robust gene delivery and therapeutic efficacy in non-human primates. BioRxiv. 2021:2021.06. 24.449775.","DOI":"10.1101\/2021.06.24.449775"},{"issue":"5","key":"2246_CR160","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/bit.27713","volume":"118","author":"YB Johari","year":"2021","unstructured":"Johari YB, Mercer AC, Liu Y, Brown AJ, James DC. Design of synthetic promoters for controlled expression of therapeutic genes in retinal pigment epithelial cells. Biotechnol Bioeng. 2021;118(5):2001\u201315. https:\/\/doi.org\/10.1002\/bit.27713.","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"2246_CR161","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/17469899.2020.1767597","volume":"15","author":"S Nashine","year":"2020","unstructured":"Nashine S, Kenney MC. Further Understanding of epigenetic dysfunction of the retinal pigment epithelium in AMD. Expert Rev Ophthalmol. 2020;15(4):221\u201331.","journal-title":"Expert Rev Ophthalmol"},{"issue":"4","key":"2246_CR162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.10.4.3","volume":"10","author":"YK Chan","year":"2021","unstructured":"Chan YK, Dick AD, Hall SM, Langmann T, Scribner CL, Mansfield BC. Ocular gene therapy inflammation working G. inflammation in viral Vector-Mediated ocular gene therapy: A review and report from a workshop hosted by the foundation fighting blindness, 9\/2020. Transl Vis Sci Technol. 2021;10(4):3. https:\/\/doi.org\/10.1167\/tvst.10.4.3.","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"2246_CR163","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.3390\/ijms25042386","volume":"25","author":"J Blasiak","year":"2024","unstructured":"Blasiak J, Pawlowska E, Ciupi\u0144ska J, Derwich M, Szczepanska J, Kaarniranta K. A new generation of gene therapies as the future of wet AMD treatment. Int J Mol Sci. 2024;25(4):2386.","journal-title":"Int J Mol Sci"},{"key":"2246_CR164","doi-asserted-by":"publisher","first-page":"1371596","DOI":"10.3389\/fbioe.2024.1371596","volume":"12","author":"AI Paremskaia","year":"2024","unstructured":"Paremskaia AI, Kogan AA, Murashkina A, Naumova DA, Satish A, Abramov IS, Feoktistova SG, Mityaeva ON, Deviatkin AA, Volchkov PY. Codon-optimization in gene therapy: promises, prospects and challenges. Front Bioeng Biotechnol. 2024;12:1371596. https:\/\/doi.org\/10.3389\/fbioe.2024.1371596.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"2246_CR165","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"J-H Wang","year":"2024","unstructured":"Wang J-H, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Therapy. 2024;9(1):78.","journal-title":"Signal Transduct Target Therapy"},{"issue":"5","key":"2246_CR166","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.survophthal.2024.05.002","volume":"69","author":"J Trincao-Marques","year":"2024","unstructured":"Trincao-Marques J, Ayton LN, Hickey DG, Marques-Neves C, Guymer RH, Edwards TL, Sousa DC. Gene and cell therapy for age-related macular degeneration: A review. Surv Ophthalmol. 2024;69(5):665\u201376. https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.002.","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"2246_CR167","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jcp.1114","volume":"188","author":"K Mori","year":"2001","unstructured":"Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol. 2001;188(2):253\u201363. https:\/\/doi.org\/10.1002\/jcp.1114.","journal-title":"J Cell Physiol"},{"issue":"7","key":"2246_CR168","first-page":"2428","volume":"43","author":"K Mori","year":"2002","unstructured":"Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2002;43(7):2428\u201334.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2246_CR169","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/hum.2006.17.167","volume":"17","author":"PA Campochiaro","year":"2006","unstructured":"Campochiaro PA, Nguyen QD, Shah SM, Klein ML, Holz E, Frank RN, Saperstein DA, Gupta A, Stout JT, Macko J, DiBartolomeo R, Wei LL. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther. 2006;17(2):167\u201376. https:\/\/doi.org\/10.1089\/hum.2006.17.167.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"2246_CR170","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/hum.2016.117","volume":"28","author":"PA Campochiaro","year":"2017","unstructured":"Campochiaro PA, Lauer AK, Sohn EH, Mir TA, Naylor S, Anderton MC, Kelleher M, Harrop R, Ellis S, Mitrophanous KA. Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study. Hum Gene Ther. 2017;28(1):99\u2013111. https:\/\/doi.org\/10.1089\/hum.2016.117.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"2246_CR171","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10456-020-09745-7","volume":"24","author":"J Chen","year":"2021","unstructured":"Chen J, Lin FL, Leung JYK, Tu L, Wang JH, Chuang YF, Li F, Shen HH, Dusting GJ, Wong VHY, Lisowski L, Hewitt AW, Bui BV, Zhong J, Liu GS. A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization. Angiogenesis. 2021;24(1):97\u2013110. https:\/\/doi.org\/10.1007\/s10456-020-09745-7.","journal-title":"Angiogenesis"},{"issue":"7","key":"2246_CR172","first-page":"294","volume":"63","author":"J Esteve-Rudd","year":"2022","unstructured":"Esteve-Rudd J, Francis J, Hughes J, Ellis S. Preclinical Pharmacology and safety of GT005, an investigational gene therapy targeting the complement pathway for the treatment of geographic atrophy. Investig Ophthalmol Vis Sci. 2022;63(7):294\u2013F. 0097-294\u2013F.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"2246_CR173","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.ophtha.2024.06.013","volume":"131","author":"JS Heier","year":"2024","unstructured":"Heier JS, Cohen MN, Chao DL, Pepio A, Shiraga Y, Capuano G, Rogers A, Ackert J, Sen HN, Csaky K. Phase 1 study of JNJ-81201887 gene therapy in geographic atrophy secondary to Age-Related macular degeneration. Ophthalmology. 2024;131(12):1377\u201388. https:\/\/doi.org\/10.1016\/j.ophtha.2024.06.013.","journal-title":"Ophthalmology"},{"issue":"1","key":"2246_CR174","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40259-023-00629-y","volume":"38","author":"BFM Castro","year":"2024","unstructured":"Castro BFM, Steel JC, Layton CJ. AAV-Based strategies for treatment of retinal and choroidal vascular diseases: advances in Age-Related macular degeneration and diabetic retinopathy therapies. BioDrugs. 2024;38(1):73\u201393. https:\/\/doi.org\/10.1007\/s40259-023-00629-y.","journal-title":"BioDrugs"},{"issue":"1","key":"2246_CR175","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000518235","volume":"245","author":"R Silva","year":"2022","unstructured":"Silva R, Arias L, Nunes S, Farinha C, Coimbra R, Marques JP, Cachulo ML, Figueira J, Barreto P, Madeira MH, Pires I, Sousa JC, Distefano L, Rosa P, Carneiro A, Vaz-Pereira S, Meireles A, Cabrera F, Bures A, Mendonca L, Fernandez-Vega-Sanz A, Barrao S, Koh A, Cheung CMG, Cunha-Vaz JG, Murta J, Group EVnAS. Efficacy and safety of intravitreal Aflibercept treat and extend for polypoidal choroidal vasculopathy in the ATLANTIC study: A randomized clinical trial. Ophthalmologica. 2022;245(1):80\u201390. https:\/\/doi.org\/10.1159\/000518235.","journal-title":"Ophthalmologica"},{"issue":"3","key":"2246_CR176","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/IIO.0000000000000366","volume":"61","author":"N Mehta","year":"2021","unstructured":"Mehta N, Robbins DA, Yiu G. Ocular inflammation and treatment emergent adverse events in retinal gene therapy. Int Ophthalmol Clin. 2021;61(3):151\u201377. https:\/\/doi.org\/10.1097\/IIO.0000000000000366.","journal-title":"Int Ophthalmol Clin"},{"issue":"9","key":"2246_CR177","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1128\/jvi.76.9.4580-4590.2002","volume":"76","author":"AK Zaiss","year":"2002","unstructured":"Zaiss AK, Liu Q, Bowen GP, Wong NC, Bartlett JS, Muruve DA. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol. 2002;76(9):4580\u201390. https:\/\/doi.org\/10.1128\/jvi.76.9.4580-4590.2002.","journal-title":"J Virol"},{"issue":"10089","key":"2246_CR178","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0140-6736(17)30979-0","volume":"390","author":"JS Heier","year":"2017","unstructured":"Heier JS, Kherani S, Desai S, Dugel P, Kaushal S, Cheng SH, Delacono C, Purvis A, Richards S, Le-Halpere A, Connelly J, Wadsworth SC, Varona R, Buggage R, Scaria A, Campochiaro PA. Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial. Lancet. 2017;390(10089):50\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(17)30979-0.","journal-title":"Lancet"},{"issue":"9","key":"2246_CR179","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","volume":"107","author":"FF Reichel","year":"2023","unstructured":"Reichel FF, Seitz I, Wozar F, Dimopoulos S, Jung R, Kempf M, Kohl S, Kortum FC, Ott S, Pohl L, Stingl K, Bartz-Schmidt KU, Stingl K, Fischer MD. Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec. Br J Ophthalmol. 2023;107(9):1331\u20135. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-321023.","journal-title":"Br J Ophthalmol"},{"key":"2246_CR180","doi-asserted-by":"crossref","unstructured":"Walters L, Palmer JG. The ethics of human gene therapy. Science. 1986;320.","DOI":"10.1038\/320225a0"},{"issue":"3","key":"2246_CR181","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"JL Shirley","year":"2020","unstructured":"Shirley JL, de Jong YP, Terhorst C, Herzog RW. Immune responses to viral gene therapy vectors. Mol Ther. 2020;28(3):709\u201322. https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.001.","journal-title":"Mol Ther"},{"key":"2246_CR182","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.omtm.2018.12.009","volume":"12","author":"S Guedan","year":"2019","unstructured":"Guedan S, Calderon H, Posey AD Jr., Maus MV. Engineering and design of chimeric antigen receptors. Mol Ther Methods Clin Dev. 2019;12:145\u201356. https:\/\/doi.org\/10.1016\/j.omtm.2018.12.009.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2246_CR183","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.omtm.2017.03.005","volume":"5","author":"X Wang","year":"2017","unstructured":"Wang X, Herzog RW, Byrne BJ, Kumar SRP, Zhou Q, Buchholz CJ, Biswas M. Immune modulatory cell therapy for hemophilia B based on CD20-Targeted lentiviral gene transfer to primary B cells. Mol Ther Methods Clin Dev. 2017;5:76\u201382. https:\/\/doi.org\/10.1016\/j.omtm.2017.03.005.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2246_CR184","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.omtm.2018.10.006","volume":"12","author":"AM Frank","year":"2019","unstructured":"Frank AM, Buchholz CJ. Surface-engineered lentiviral vectors for selective gene transfer into subtypes of lymphocytes. Mol Therapy-Methods Clin Dev. 2019;12:19\u201331.","journal-title":"Mol Therapy-Methods Clin Dev"},{"key":"2246_CR185","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.omtm.2019.03.003","volume":"13","author":"A Jamali","year":"2019","unstructured":"Jamali A, Kapitza L, Schaser T, Johnston ICD, Buchholz CJ, Hartmann J. Highly efficient and selective CAR-Gene transfer using CD4- and CD8-Targeted lentiviral vectors. Mol Ther Methods Clin Dev. 2019;13:371\u20139. https:\/\/doi.org\/10.1016\/j.omtm.2019.03.003.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"493","key":"2246_CR186","doi-asserted-by":"publisher","first-page":"eaav7325","DOI":"10.1126\/scitranslmed.aav7325","volume":"11","author":"M Milani","year":"2019","unstructured":"Milani M, Annoni A, Moalli F, Liu T, Cesana D, Calabria A, Bartolaccini S, Biffi M, Russo F, Visigalli I, Raimondi A, Patarroyo-White S, Drager D, Cristofori P, Ayuso E, Montini E, Peters R, Iannacone M, Cantore A, Naldini L. Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Sci Transl Med. 2019;11(493):eaav7325. https:\/\/doi.org\/10.1126\/scitranslmed.aav7325.","journal-title":"Sci Transl Med"},{"issue":"7","key":"2246_CR187","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1182\/blood-2006-10-049312","volume":"109","author":"BD Brown","year":"2007","unstructured":"Brown BD, Sitia G, Annoni A, Hauben E, Sergi LS, Zingale A, Roncarolo MG, Guidotti LG, Naldini L. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood. 2007;109(7):2797\u2013805.","journal-title":"Blood"},{"issue":"12","key":"2246_CR188","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/mt.2012.150","volume":"20","author":"J Agudo","year":"2012","unstructured":"Agudo J, Ruzo A, Kitur K, Sachidanandam R, Blander JM, Brown BD. A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by Pharmacological Blockade. Mol Ther. 2012;20(12):2257\u201367.","journal-title":"Mol Ther"},{"key":"2246_CR189","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.coviro.2016.08.016","volume":"21","author":"C Borsotti","year":"2016","unstructured":"Borsotti C, Borroni E, Follenzi A. Lentiviral vector interactions with the host cell. Curr Opin Virol. 2016;21:102\u20138. https:\/\/doi.org\/10.1016\/j.coviro.2016.08.016.","journal-title":"Curr Opin Virol"},{"issue":"2","key":"2246_CR190","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/hum.2010.085","volume":"22","author":"M Rossetti","year":"2011","unstructured":"Rossetti M, Gregori S, Hauben E, Brown BD, Sergi LS, Naldini L, Roncarolo M-G. HIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells. Hum Gene Ther. 2011;22(2):177\u201388.","journal-title":"Hum Gene Ther"},{"issue":"2","key":"2246_CR191","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/JVI.01818-06","volume":"81","author":"A Pichlmair","year":"2007","unstructured":"Pichlmair A, Diebold SS, Gschmeissner S, Takeuchi Y, Ikeda Y, Collins MK, Reis e Sousa C. Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9. J Virol. 2007;81(2):539\u201347.","journal-title":"J Virol"},{"issue":"1","key":"2246_CR192","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/ni.2767","volume":"15","author":"J Agudo","year":"2014","unstructured":"Agudo J, Ruzo A, Tung N, Salmon H, Leboeuf M, Hashimoto D, Becker C, Garrett-Sinha LA, Baccarini A, Merad M, Brown BD. The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids. Nat Immunol. 2014;15(1):54\u201362. https:\/\/doi.org\/10.1038\/ni.2767.","journal-title":"Nat Immunol"},{"issue":"2","key":"2246_CR193","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/mt.2013.299","volume":"22","author":"GL Rogers","year":"2014","unstructured":"Rogers GL, Herzog RW. One MicroRNA controls both angiogenesis and TLR-mediated innate immunity to nucleic acids. Mol Ther. 2014;22(2):249\u201350.","journal-title":"Mol Ther"},{"issue":"6148","key":"2246_CR194","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1240933","volume":"341","author":"D Gao","year":"2013","unstructured":"Gao D, Wu J, Wu Y-T, Du F, Aroh C, Yan N, Sun L, Chen ZJ. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science. 2013;341(6148):903\u20136.","journal-title":"Science"},{"issue":"6","key":"2246_CR195","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2013.11.002","volume":"39","author":"X Lahaye","year":"2013","unstructured":"Lahaye X, Satoh T, Gentili M, Cerboni S, Conrad C, Hurbain I, El Marjou A, Lacabaratz C, Lelievre JD, Manel N. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity. 2013;39(6):1132\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2013.11.002.","journal-title":"Immunity"},{"issue":"2","key":"2246_CR196","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41433-021-01842-1","volume":"36","author":"AM Khanani","year":"2022","unstructured":"Khanani AM, Thomas MJ, Aziz AA, Weng CY, Danzig CJ, Yiu G, Kiss S, Waheed NK, Kaiser PK. Review of gene therapies for age-related macular degeneration. Eye (Lond). 2022;36(2):303\u201311. https:\/\/doi.org\/10.1038\/s41433-021-01842-1.","journal-title":"Eye (Lond)"},{"issue":"10436","key":"2246_CR197","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S0140-6736(24)00310-6","volume":"403","author":"PA Campochiaro","year":"2024","unstructured":"Campochiaro PA, Avery R, Brown DM, Heier JS, Ho AC, Huddleston SM, Jaffe GJ, Khanani AM, Pakola S, Pieramici DJ, Wykoff CC, Van Everen S. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1\/2a dose-escalation study. Lancet. 2024;403(10436):1563\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(24)00310-6.","journal-title":"Lancet"},{"issue":"1","key":"2246_CR198","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajo.2014.03.014","volume":"158","author":"RB Nussenblatt","year":"2014","unstructured":"Nussenblatt RB, Lee RW, Chew E, Wei L, Liu B, Sen HN, Dick AD, Ferris FL. Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention. Am J Ophthalmol. 2014;158(1):5\u2013e112. https:\/\/doi.org\/10.1016\/j.ajo.2014.03.014.","journal-title":"Am J Ophthalmol"},{"issue":"17\u201318","key":"2246_CR199","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1089\/hum.2022.159","volume":"33","author":"SY Cheng","year":"2022","unstructured":"Cheng SY, Punzo C. Update on viral gene therapy clinical trials for retinal diseases. Hum Gene Ther. 2022;33(17\u201318):865\u201378. https:\/\/doi.org\/10.1089\/hum.2022.159.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"2246_CR200","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1538-7836.2006.02220.x","volume":"5","author":"T Vandendriessche","year":"2007","unstructured":"Vandendriessche T, Thorrez L, Acosta-Sanchez A, Petrus I, Wang L, Ma L, L DEW, Iwasaki Y, Gillijns V, Wilson JM, Collen D, Chuah MK. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost. 2007;5(1):16\u201324. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02220.x.","journal-title":"J Thromb Haemost"},{"key":"2246_CR201","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.omtm.2022.07.018","volume":"26","author":"TY Yang","year":"2022","unstructured":"Yang TY, Braun M, Lembke W, McBlane F, Kamerud J, DeWall S, Tarcsa E, Fang X, Hofer L, Kavita U, Upreti VV, Gupta S, Loo L, Johnson AJ, Chandode RK, Stubenrauch KG, Vinzing M, Xia CQ, Jawa V. Immunogenicity assessment of AAV-based gene therapies: an IQ consortium industry white paper. Mol Ther Methods Clin Dev. 2022;26:471\u201394. https:\/\/doi.org\/10.1016\/j.omtm.2022.07.018.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"2246_CR202","first-page":"2284","volume":"56","author":"S Chandler","year":"2015","unstructured":"Chandler S, Campochiaro P, Lauer A, Sohn EH, Stout T, Kelleher M, Harrop R, Ellis S, Mitrophanous K. Results from the phase i GEM study, evaluating safety and tolerability of subretinally-injected lentiviral vector (retinostat\u00ae) for the treatment of wet age-related macular degeneration (AMD). Investig Ophthalmol Vis Sci. 2015;56(7):2284.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2246_CR203","doi-asserted-by":"publisher","first-page":"103802DOI","DOI":"10.1016\/j.cellimm.2018.04.012","volume":"342","author":"A Annoni","year":"2019","unstructured":"Annoni A, Gregori S, Naldini L, Cantore A. Modulation of immune responses in lentiviral vector-mediated gene transfer. Cell Immunol. 2019;342:103802DOI. https:\/\/doi.org\/10.1016\/j.cellimm.2018.04.012.","journal-title":"Cell Immunol"},{"issue":"6","key":"2246_CR204","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/hum.2005.16.741","volume":"16","author":"E Abordo-Adesida","year":"2005","unstructured":"Abordo-Adesida E, Follenzi A, Barcia C, Sciascia S, Castro MG, Naldini L, Lowenstein PR. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther. 2005;16(6):741\u201351. https:\/\/doi.org\/10.1089\/hum.2005.16.741.","journal-title":"Hum Gene Ther"},{"issue":"1","key":"2246_CR205","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000526317","volume":"66","author":"BP Leroy","year":"2023","unstructured":"Leroy BP, Fischer MD, Flannery JG, MacLaren RE, Dalkara D, Scholl HPN, Chung DC, Spera C, Viriato D, Banhazi J. Gene therapy for inherited retinal disease: Long-Term durability of effect. Ophthalmic Res. 2023;66(1):179\u201396. https:\/\/doi.org\/10.1159\/000526317.","journal-title":"Ophthalmic Res"},{"issue":"6","key":"2246_CR206","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/hmg\/ddu588","volume":"24","author":"T Zhang","year":"2015","unstructured":"Zhang T, Enemchukwu NO, Jones A, Wang S, Dennis E, Watt CB, Pugh EN Jr., Fu Y. Genetic deletion of S-opsin prevents rapid cone degeneration in a mouse model of leber congenital amaurosis. Hum Mol Genet. 2015;24(6):1755\u201363. https:\/\/doi.org\/10.1093\/hmg\/ddu588.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2246_CR207","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","volume":"130","author":"SG Jacobson","year":"2012","unstructured":"Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, Conlon TJ, Calcedo R, Pang JJ, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130(1):9\u201324. https:\/\/doi.org\/10.1001\/archophthalmol.2011.298.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"2246_CR208","first-page":"3398","volume":"60","author":"DC Chung","year":"2019","unstructured":"Chung DC, Lee K, Reape KZ, High KA, Lacey S, Viriato D. Long-Term effect of voretigene neparvovec on the Full-Field light sensitivity threshold test of patients with RPE65 mutation-associated inherited retinal dystrophy\u2013post hoc analysis of phase I trial data. Investig Ophthalmol Vis Sci. 2019;60(9):3398.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"2246_CR209","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/hum.2006.17.845","volume":"17","author":"SG Jacobson","year":"2006","unstructured":"Jacobson SG, Boye SL, Aleman TS, Conlon TJ, Zeiss CJ, Roman AJ, Cideciyan AV, Schwartz SB, Komaromy AM, Doobrajh M, Cheung AY, Sumaroka A, Pearce-Kelling SE, Aguirre GD, Kaushal S, Maguire AM, Flotte TR, Hauswirth WW. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in leber congenital amaurosis. Hum Gene Ther. 2006;17(8):845\u201358. https:\/\/doi.org\/10.1089\/hum.2006.17.845.","journal-title":"Hum Gene Ther"},{"issue":"16","key":"2246_CR210","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1093\/hmg\/ddr218","volume":"20","author":"LS Carvalho","year":"2011","unstructured":"Carvalho LS, Xu J, Pearson RA, Smith AJ, Bainbridge JW, Morris LM, Fliesler SJ, Ding XQ, Ali RR. Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet. 2011;20(16):3161\u201375. https:\/\/doi.org\/10.1093\/hmg\/ddr218.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"2246_CR211","first-page":"3309","volume":"55","author":"S-H Min","year":"2014","unstructured":"Min S-H, Ruan Q, Boye SL, Boye S, Hauswirth WW, Kay CN. Expression of CNGB3 provides long-term rescue in the cone-only CNGB3 X NRL double knock-out (DKO) mouse. Investig Ophthalmol Vis Sci. 2014;55(13):3309.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"2246_CR212","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/humc.2015.163","volume":"27","author":"GJ Ye","year":"2016","unstructured":"Ye GJ, Budzynski E, Sonnentag P, Nork TM, Miller PE, McPherson L, Ver Hoeve JN, Smith LM, Arndt T, Mandapati S, Robinson PM, Calcedo R, Knop DR, Hauswirth WW, Chulay JD. Safety and biodistribution evaluation in CNGB3-Deficient mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV vector for treatment of achromatopsia. Hum Gene Ther Clin Dev. 2016;27(1):27\u201336. https:\/\/doi.org\/10.1089\/humc.2015.163.","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"1","key":"2246_CR213","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/hum.2015.130","volume":"27","author":"GJ Ye","year":"2016","unstructured":"Ye GJ, Budzynski E, Sonnentag P, Nork TM, Sheibani N, Gurel Z, Boye SL, Peterson JJ, Boye SE, Hauswirth WW, Chulay JD. Cone-Specific promoters for gene therapy of achromatopsia and other retinal diseases. Hum Gene Ther. 2016;27(1):72\u201382. https:\/\/doi.org\/10.1089\/hum.2015.130.","journal-title":"Hum Gene Ther"},{"issue":"2","key":"2246_CR214","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7555\/JBR.33.20190056","volume":"34","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang S, Xu M, Pang J, Yuan Z, Zhao C. AAV-mediated human CNGB3 restores cone function in an all-cone mouse model of CNGB3 achromatopsia. J Biomedical Res. 2020;34(2):114.","journal-title":"J Biomedical Res"},{"issue":"13","key":"2246_CR215","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1093\/hmg\/ddq136","volume":"19","author":"AM Komaromy","year":"2010","unstructured":"Komaromy AM, Alexander JJ, Rowlan JS, Garcia MM, Chiodo VA, Kaya A, Tanaka JC, Acland GM, Hauswirth WW, Aguirre GD. Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet. 2010;19(13):2581\u201393. https:\/\/doi.org\/10.1093\/hmg\/ddq136.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2246_CR216","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/mt.2013.50","volume":"21","author":"AM Komaromy","year":"2013","unstructured":"Komaromy AM, Rowlan JS, Corr AT, Reinstein SL, Boye SL, Cooper AE, Gonzalez A, Levy B, Wen R, Hauswirth WW, Beltran WA, Aguirre GD. Transient photoreceptor Deconstruction by CNTF enhances rAAV-mediated cone functional rescue in late stage CNGB3-achromatopsia. Mol Ther. 2013;21(6):1131\u201341. https:\/\/doi.org\/10.1038\/mt.2013.50.","journal-title":"Mol Ther"},{"issue":"4","key":"2246_CR217","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/humc.2017.125","volume":"28","author":"GJ Ye","year":"2017","unstructured":"Ye GJ, Komaromy AM, Zeiss C, Calcedo R, Harman CD, Koehl KL, Stewart GA, Iwabe S, Chiodo VA, Hauswirth WW, Aguirre GD, Chulay JD. Safety and efficacy of AAV5 vectors expressing human or canine CNGB3 in CNGB3-Mutant dogs. Hum Gene Ther Clin Dev. 2017;28(4):197\u2013207. https:\/\/doi.org\/10.1089\/humc.2017.125.","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"1","key":"2246_CR218","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/humc.2015.164","volume":"27","author":"GJ Ye","year":"2016","unstructured":"Ye GJ, Budzynski E, Sonnentag P, Nork TM, Miller PE, Sharma AK, Ver Hoeve JN, Smith LM, Arndt T, Calcedo R, Gaskin C, Robinson PM, Knop DR, Hauswirth WW, Chulay JD. Safety and biodistribution evaluation in Cynomolgus macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV vector for treatment of achromatopsia. Hum Gene Ther Clin Dev. 2016;27(1):37\u201348. https:\/\/doi.org\/10.1089\/humc.2015.164.","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"20","key":"2246_CR219","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1093\/hmg\/dds290","volume":"21","author":"S Koch","year":"2012","unstructured":"Koch S, Sothilingam V, Garcia Garrido M, Tanimoto N, Becirovic E, Koch F, Seide C, Beck SC, Seeliger MW, Biel M, Muhlfriedel R, Michalakis S. Gene therapy restores vision and delays degeneration in the CNGB1(-\/-) mouse model of retinitis pigmentosa. Hum Mol Genet. 2012;21(20):4486\u201396. https:\/\/doi.org\/10.1093\/hmg\/dds290.","journal-title":"Hum Mol Genet"},{"key":"2246_CR220","volume-title":"Gene therapy restores vision and delays degeneration in the CNGB1\u2013\/\u2013 mouse model of retinitis pigmentosa","year":"2014","unstructured":"Michalakis S, Koch S, Sothilingam V, Garrido MG, Tanimoto N, Schulze E, Becirovic E, Koch F, Seide C, Beck SC, editors. Gene therapy restores vision and delays degeneration in the CNGB1\u2013\/\u2013 mouse model of retinitis pigmentosa. Retinal Degenerative Diseases: Mechanisms and Experimental Therapy; 2014."},{"issue":"12","key":"2246_CR221","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1089\/hum.2017.156","volume":"28","author":"C Schon","year":"2017","unstructured":"Schon C, Sothilingam V, Muhlfriedel R, Garcia Garrido M, Beck SC, Tanimoto N, Wissinger B, Paquet-Durand F, Biel M, Michalakis S, Seeliger MW. Gene therapy successfully delays degeneration in a mouse model of PDE6A-Linked retinitis pigmentosa (RP43). Hum Gene Ther. 2017;28(12):1180\u20138. https:\/\/doi.org\/10.1089\/hum.2017.156.","journal-title":"Hum Gene Ther"},{"issue":"2","key":"2246_CR222","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/hmg\/ddt452","volume":"23","author":"KJ Wert","year":"2014","unstructured":"Wert KJ, Sancho-Pelluz J, Tsang SH. Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa. Hum Mol Genet. 2014;23(2):514\u201323.","journal-title":"Hum Mol Genet"},{"key":"2246_CR223","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fnins.2017.00342","volume":"11","author":"FM Mowat","year":"2017","unstructured":"Mowat FM, Occelli LM, Bartoe JT, Gervais KJ, Bruewer AR, Querubin J, Dinculescu A, Boye SL, Hauswirth WW, Petersen-Jones SM. Gene therapy in a large animal model of PDE6A-Retinitis pigmentosa. Front Neurosci. 2017;11:342. https:\/\/doi.org\/10.3389\/fnins.2017.00342.","journal-title":"Front Neurosci"},{"issue":"12","key":"2246_CR224","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1089\/hum.2017.155","volume":"28","author":"LM Occelli","year":"2017","unstructured":"Occelli LM, Schon C, Seeliger MW, Biel M, Michalakis S, Petersen-Jones SM. Gene supplementation rescues rod function and preserves photoreceptor and retinal morphology in dogs, leading the way toward treating human PDE6A-Retinitis pigmentosa. Hum Gene Ther. 2017;28(12):1189\u2013201. https:\/\/doi.org\/10.1089\/hum.2017.155.","journal-title":"Hum Gene Ther"},{"issue":"8","key":"2246_CR225","first-page":"4096","volume":"58","author":"T Peters","year":"2017","unstructured":"Peters T, Wilhelm B, Korte S, Bartz-Schmidt KU, Michalakis S, Ochakovski GA, Fischer DM. Evaluation of electroretinography in cynomolgus monkeys after subretinal injection of rAAV. hPDE6A. Investig Ophthalmol Vis Sci. 2017;58(8):4096.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"2246_CR226","doi-asserted-by":"publisher","first-page":"6006","DOI":"10.1038\/ncomms7006","volume":"6","author":"KM Nishiguchi","year":"2015","unstructured":"Nishiguchi KM, Carvalho LS, Rizzi M, Powell K, Holthaus SM, Azam SA, Duran Y, Ribeiro J, Luhmann UF, Bainbridge JW, Smith AJ, Ali RR. Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179. Nat Commun. 2015;6(1):6006. https:\/\/doi.org\/10.1038\/ncomms7006.","journal-title":"Nat Commun"},{"issue":"10","key":"2246_CR227","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1167\/iovs.07-1622","volume":"49","author":"JJ Pang","year":"2008","unstructured":"Pang JJ, Boye SL, Kumar A, Dinculescu A, Deng W, Li J, Li Q, Rani A, Foster TC, Chang B, Hawes NL, Boatright JH, Hauswirth WW. AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation. Invest Ophthalmol Vis Sci. 2008;49(10):4278\u201383. https:\/\/doi.org\/10.1167\/iovs.07-1622.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2246_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.joco.2018.01.006","volume":"30","author":"H Ameri","year":"2018","unstructured":"Ameri H. Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation. J Curr Ophthalmol. 2018;30(1):1\u20132. https:\/\/doi.org\/10.1016\/j.joco.2018.01.006.","journal-title":"J Curr Ophthalmol"},{"issue":"3","key":"2246_CR229","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11095-007-9431-0","volume":"25","author":"I Kwon","year":"2008","unstructured":"Kwon I, Schaffer DV. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res. 2008;25(3):489\u201399. https:\/\/doi.org\/10.1007\/s11095-007-9431-0.","journal-title":"Pharm Res"},{"issue":"9","key":"2246_CR230","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1128\/JVI.73.9.7812-7816.1999","volume":"73","author":"M Takahashi","year":"1999","unstructured":"Takahashi M, Miyoshi H, Verma IM, Gage FH. Rescue from photoreceptor degeneration in the Rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Virol. 1999;73(9):7812\u20136. https:\/\/doi.org\/10.1128\/JVI.73.9.7812-7816.1999.","journal-title":"J Virol"},{"issue":"9","key":"2246_CR231","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1172\/JCI82462","volume":"125","author":"SF Koch","year":"2015","unstructured":"Koch SF, Tsai YT, Duong JK, Wu WH, Hsu CW, Wu WP, Bonet-Ponce L, Lin CS, Tsang SH. Halting progressive neurodegeneration in advanced retinitis pigmentosa. J Clin Invest. 2015;125(9):3704\u201313. https:\/\/doi.org\/10.1172\/JCI82462.","journal-title":"J Clin Invest"},{"issue":"10","key":"2246_CR232","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1258\/ebm.2011.011053","volume":"236","author":"J Tosi","year":"2011","unstructured":"Tosi J, Sancho-Pelluz J, Davis RJ, Hsu CW, Wolpert KV, Sengillo JD, Lin CS, Tsang SH. Lentivirus-mediated expression of cDNA and ShRNA slows degeneration in retinitis pigmentosa. Exp Biol Med (Maywood). 2011;236(10):1211\u20137. https:\/\/doi.org\/10.1258\/ebm.2011.011053.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"2246_CR233","doi-asserted-by":"publisher","first-page":"e37197","DOI":"10.1371\/journal.pone.0037197","volume":"7","author":"J Yao","year":"2012","unstructured":"Yao J, Jia L, Khan N, Zheng Q-D, Moncrief A, Hauswirth WW, Thompson DA, Zacks DN. Caspase Inhibition with XIAP as an adjunct to AAV vector gene-replacement therapy: improving efficacy and prolonging the treatment window. PLoS ONE. 2012;7(5):e37197.","journal-title":"PLoS ONE"},{"key":"2246_CR234","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2017.10.004","volume":"63","author":"MF Dias","year":"2018","unstructured":"Dias MF, Joo K, Kemp JA, Fialho SL, da Silva Cunha A Jr., Woo SJ, Kwon YJ. Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives. Prog Retin Eye Res. 2018;63:107\u201331. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.004.","journal-title":"Prog Retin Eye Res"},{"key":"2246_CR235","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","volume":"4","author":"F Mingozzi","year":"2017","unstructured":"Mingozzi F, High KA. Overcoming the host immune response to adeno-associated virus gene delivery vectors: the race between clearance, tolerance, neutralization, and escape. Annual Rev Virol. 2017;4:511\u201334.","journal-title":"Annual Rev Virol"},{"issue":"9","key":"2246_CR236","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/CVI.05107-11","volume":"18","author":"R Calcedo","year":"2011","unstructured":"Calcedo R, Morizono H, Wang L, McCarter R, He J, Jones D, Batshaw ML, Wilson JM. Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin Vaccine Immunol. 2011;18(9):1586\u20138. https:\/\/doi.org\/10.1128\/CVI.05107-11.","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"2246_CR237","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/gt.2011.90","volume":"19","author":"C Li","year":"2012","unstructured":"Li C, Narkbunnam N, Samulski RJ, Asokan A, Hu G, Jacobson LJ, Manco-Johnson MJ, Monahan PE. Joint outcome study I. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene Ther. 2012;19(3):288\u201394. https:\/\/doi.org\/10.1038\/gt.2011.90.","journal-title":"Gene Ther"},{"key":"2246_CR238","doi-asserted-by":"crossref","unstructured":"Gao G-P, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proceedings of the National Academy of Sciences. 2002;99(18):11854-9.","DOI":"10.1073\/pnas.182412299"},{"issue":"3","key":"2246_CR239","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12(3):342\u20137. https:\/\/doi.org\/10.1038\/nm1358.","journal-title":"Nat Med"},{"issue":"10","key":"2246_CR240","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","volume":"108","author":"H Jiang","year":"2006","unstructured":"Jiang H, Couto LB, Patarroyo-White S, Liu T, Nagy D, Vargas JA, Zhou S, Scallan CD, Sommer J, Vijay S, Mingozzi F, High KA, Pierce GF. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. Blood. 2006;108(10):3321\u20138. https:\/\/doi.org\/10.1182\/blood-2006-04-017913.","journal-title":"Blood"},{"issue":"5","key":"2246_CR241","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2005-08-3229","volume":"107","author":"CD Scallan","year":"2006","unstructured":"Scallan CD, Jiang H, Liu T, Patarroyo-White S, Sommer JM, Zhou S, Couto LB, Pierce GF. Human Immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Blood. 2006;107(5):1810\u20137.","journal-title":"Blood"},{"issue":"2","key":"2246_CR242","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/hgtb.2015.037","volume":"26","author":"A Meliani","year":"2015","unstructured":"Meliani A, Leborgne C, Triffault S, Jeanson-Leh L, Veron P, Mingozzi F. Determination of anti-adeno-associated virus vector neutralizing antibody titer with an in vitro reporter system. Hum Gene Ther Methods. 2015;26(2):45\u201353. https:\/\/doi.org\/10.1089\/hgtb.2015.037.","journal-title":"Hum Gene Ther Methods"},{"issue":"8","key":"2246_CR243","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","volume":"101","author":"CS Manno","year":"2003","unstructured":"Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, Tai SJ, Ragni MV, Thompson A, Ozelo M, Couto LB, Leonard DG, Johnson FA, McClelland A, Scallan C, Skarsgard E, Flake AW, Kay MA, High KA, Glader B. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. 2003;101(8):2963\u201372. https:\/\/doi.org\/10.1182\/blood-2002-10-3296.","journal-title":"Blood"},{"issue":"4","key":"2246_CR244","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet. 2020;21(4):255\u201372. https:\/\/doi.org\/10.1038\/s41576-019-0205-4.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"2246_CR245","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/sj.mt.6300355","volume":"16","author":"Z Wu","year":"2008","unstructured":"Wu Z, Sun J, Zhang T, Yin C, Yin F, Van Dyke T, Samulski RJ, Monahan PE. Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose. Mol Ther. 2008;16(2):280\u20139.","journal-title":"Mol Ther"},{"issue":"26","key":"2246_CR246","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","volume":"377","author":"S Rangarajan","year":"2017","unstructured":"Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M, Yu H, Vettermann C, Pierce GF, Wong WY, Pasi KJ. AAV5-Factor VIII gene transfer in severe hemophilia A. N Engl J Med. 2017;377(26):2519\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1708483.","journal-title":"N Engl J Med"},{"issue":"9","key":"2246_CR247","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/mt.2014.114","volume":"22","author":"MK Chuah","year":"2014","unstructured":"Chuah MK, Petrus I, De Bleser P, Le Guiner C, Gernoux G, Adjali O, Nair N, Willems J, Evens H, Rincon MY, Matrai J, Di Matteo M, Samara-Kuko E, Yan B, Acosta-Sanchez A, Meliani A, Cherel G, Blouin V, Christophe O, Moullier P, Mingozzi F, VandenDriessche T. Liver-specific transcriptional modules identified by genome-wide in Silico analysis enable efficient gene therapy in mice and non-human primates. Mol Ther. 2014;22(9):1605\u201313. https:\/\/doi.org\/10.1038\/mt.2014.114.","journal-title":"Mol Ther"},{"issue":"1","key":"2246_CR248","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/mt.2014.178","volume":"23","author":"MY Rincon","year":"2015","unstructured":"Rincon MY, Sarcar S, Danso-Abeam D, Keyaerts M, Matrai J, Samara-Kuko E, Acosta-Sanchez A, Athanasopoulos T, Dickson G, Lahoutte T. Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional cis-regulatory motifs that enable efficient cardiac gene therapy. Mol Ther. 2015;23(1):43\u201352.","journal-title":"Mol Ther"},{"key":"2246_CR249","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtm.2018.01.004","volume":"9","author":"HC Brown","year":"2018","unstructured":"Brown HC, Zakas PM, George SN, Parker ET, Spencer HT, Doering CB. Target-Cell-Directed bioengineering approaches for gene therapy of hemophilia A. Mol Ther Methods Clin Dev. 2018;9:57\u201369. https:\/\/doi.org\/10.1016\/j.omtm.2018.01.004.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"2246_CR250","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/mt.2011.237","volume":"20","author":"DE Bowles","year":"2012","unstructured":"Bowles DE, McPhee SW, Li C, Gray SJ, Samulski JJ, Camp AS, Li J, Wang B, Monahan PE, Rabinowitz JE, Grieger JC, Govindasamy L, Agbandje-McKenna M, Xiao X, Samulski RJ. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther. 2012;20(2):443\u201355. https:\/\/doi.org\/10.1038\/mt.2011.237.","journal-title":"Mol Ther"},{"issue":"5","key":"2246_CR251","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/hum.2015.025","volume":"26","author":"E Hastie","year":"2015","unstructured":"Hastie E, Samulski RJ. Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success\u2014a personal perspective. Hum Gene Ther. 2015;26(5):257\u201365.","journal-title":"Hum Gene Ther"},{"key":"2246_CR252","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-4939-3271-9_2","volume":"1382","author":"ML Hirsch","year":"2016","unstructured":"Hirsch ML, Wolf SJ, Samulski RJ. Delivering Transgenic DNA exceeding the carrying capacity of AAV vectors. Methods Mol Biol. 2016;1382:21\u201339. https:\/\/doi.org\/10.1007\/978-1-4939-3271-9_2.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"2246_CR253","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1089\/hum.2013.164","volume":"25","author":"T Koo","year":"2014","unstructured":"Koo T, Popplewell L, Athanasopoulos T, Dickson G. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Hum Gene Ther. 2014;25(2):98\u2013108.","journal-title":"Hum Gene Ther"},{"issue":"12","key":"2246_CR254","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/mt.2013.184","volume":"21","author":"ML Hirsch","year":"2013","unstructured":"Hirsch ML, Li C, Bellon I, Yin C, Chavala S, Pryadkina M, Richard I, Samulski RJ. Oversized AAV transductifon is mediated via a DNA-PKcs-independent, Rad51C-dependent repair pathway. Mol Ther. 2013;21(12):2205\u201316.","journal-title":"Mol Ther"},{"key":"2246_CR255","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.omtm.2019.01.003","volume":"12","author":"J Fakhiri","year":"2019","unstructured":"Fakhiri J, Schneider MA, Puschhof J, Stanifer M, Schildgen V, Holderbach S, Voss Y, El Andari J, Schildgen O, Boulant S, Meister M, Clevers H, Yan Z, Qiu J, Grimm D. Novel chimeric gene therapy vectors based on Adeno-Associated virus and four different mammalian bocaviruses. Mol Ther Methods Clin Dev. 2019;12:202\u201322. https:\/\/doi.org\/10.1016\/j.omtm.2019.01.003.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"492","key":"2246_CR256","doi-asserted-by":"publisher","first-page":"eaav","DOI":"10.1126\/scitranslmed.aav4523","volume":"11","author":"P Tornabene","year":"2019","unstructured":"Tornabene P, Trapani I, Minopoli R, Centrulo M, Lupo M, de Simone S, Tiberi P, Dell\u2019Aquila F, Marrocco E, Iodice C, Iuliano A, Gesualdo C, Rossi S, Giaquinto L, Albert S, Hoyng CB, Polishchuk E, Cremers FPM, Surace EM, Simonelli F, De Matteis MA, Polishchuk R, Auricchio A. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci Transl Med. 2019;11(492):eaav. https:\/\/doi.org\/10.1126\/scitranslmed.aav4523.","journal-title":"Sci Transl Med"},{"issue":"2","key":"2246_CR257","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases6020042","volume":"6","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom K. Viral vectors in gene therapy. Diseases. 2018;6(2):42. https:\/\/doi.org\/10.3390\/diseases6020042.","journal-title":"Diseases"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02246-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T07:07:33Z","timestamp":1747724853000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":257,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02246-4","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the review and given their consent to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}